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THESIS ABSTRACT  
Introduction 
This thesis focusses on ankle foot orthoses (AFO) and functional electrical stimulation (FES) 
for the correction of foot-drop. It consists of two parts linked through identification of three 
gaps in the knowledge base: 1) limitations in device design, 2) limitations in device 
evaluation and 3) a lack of clear clinical guidance surrounding which of the two devices to 
use. 
Methods and Results 
PART 1 reports on the design and evaluation of an AFO alternative (dorsiflex sock) and an 
alternative to conventional FES systems (ShefStim®). Article 1 reports the evaluation of the 
researcher/user co-design approach used in the development of both devices, finding that 
lay-advisory involvement guided aspects such as where to locate the stimulator and 
informed the revision of the evaluation studies. Article 2 used a single case experimental 
design with 2 stroke participants to preliminarily explore the efficacy and user views of the 
dorsiflex sock. It found no clear evidence to demonstrate that the dorsiflex sock with its 
current design was effective, despite user views to the contrary. 
Article 3 reported on the feasibility of ShefStim®. Seven current foot-drop FES users used 
ShefStim® unsupervised for two weeks at home, alongside gait laboratory testing of foot-
clearance and kinematics at initial contact. Number of heel rises in day-day use was logged, 
as well as user satisfaction, donning/setup times and diary data. This data demonstrated 
that ShefStim® could be used in the community. Lab-based testing suggested that ShefStim® 
was comparable to conventional FES systems with regards kinematics at initial contact and 
foot-clearance. User satisfaction was comparable for both devices. However, further 
product refinement around setup and the electrode array-skin interface is necessary to 
make ShefStim® commercially viable.  Article 4 reports on the design, development and 
evaluation of ShefStim®. 
PART 2 comprises two meta-analyses focussing on orthotic (Article 5) and therapeutic 
(Article 6) effects. Article 5 revealed statistically comparable positive orthotic effects on 
walking speed, exercise capacity and the stroke impact scale. Article 6 found comparable 
therapeutic speed increases, but both reviews highlighted the lack of high quality evidence 
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on use of each device outside of the laboratory. It was not possible draw any conclusions 
about the mechanisms-of-action underlying these findings. 
Conclusion and future study 
The dorsiflex sock and ShefStim® are both feasible devices and the novel approaches taken 
to their evaluation merit wider use in the field.  Further work is necessary to improve the 
design of both devices before definitive clinical trials are carried out.  
Despite AFO and FES showing similar levels of efficacy there is very little published work on 
the real world evaluation of either type of device or foot-drop specific mechanistic 
evaluations that might help to guide clinical choice. Therefore, this thesis highlights the 
need for further comparative randomised controlled trials, focussing on biomechanical and 
real world measures, informed by potential end-users. 
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CHAPTER 1: CONTEXTUAL BACKGROUND 
1.1 Walking 
Independent walking is a primary goal for most people with disorders of central neurological 
origin (CNO) such as cerebrovascular accident/stroke, cerebral palsy (CP), multiple sclerosis 
(MS) or other brain injury (BI) or spinal cord injury (SCI)  (de Wit, Buurke, Nijlant, IJzerman, 
& Hermens, 2004; Dobkin, 2005; Intercollegiate Stroke Working Party, 2016) as well as their 
families and health professionals (Condie, Campbell, & Martina, 2004). Functional walking 
has been characterised by five key features (Baker, 2013). Crucially these include the ability 
to clear the foot sufficiently during swing and having a smooth transition from swing to 
stance. These abilities are frequently disrupted by what is known as foot-drop/ drop foot/ 
equinus/ equinovarus.  
 
1.2 Foot-drop 
Although the literature on prevalence of foot-drop is both old and reports on limited 
numbers of participants, foot-drop is estimated to be present in around 20% of the most 
prevalent of the CNO disorders population, stroke (Verdié et al., 2004; Wade, Wood, Heller, 
Maggs, & Langton Hewer, 1987). Prevalence data is not published for other CNO disorders 
but, based on the stroke numbers alone, there are approximately 240,000 people in the 
United Kingdom (UK) who may have foot-drop (Stroke Association, 2016).  
Foot-drop gait is characterised by a lack of ankle dorsiflexion (DF) (Dunning, O'Dell, Kluding, 
& McBride, 2015) often accompanied by a lack of eversion. This is a result of what is 
referred to as the upper motor neuron syndrome (UMNS) (Carr & Shepherd, 2010; Sheean 
& McGuire, 2009) where negative features such as weakness/ paralysis sit alongside positive 
features such as spasticity. These, in combination with imposed immobility and disuse, leads 
over time to secondary musculoskeletal issues such as increased muscle stiffness, often 
termed adaptive features (Carr & Shepherd, 2010).  
In the case of foot-drop the UMNS causes an imbalance between the activity in muscles of 
the anterior compartment of the lower leg (Figure 1: left) and triceps surae complex 
posteriorly (Carr & Shepherd, 2010) (Figure 1: middle and right).  
10 
 
Figure 1: Muscles of the Lower Leg by OpenStax licensed under CC BY 4.0. 
Foot-drop affects both the stance and swing periods of the gait cycle but fundamentally it 
makes the ability to clear the foot during swing more challenging, which increases the risk of 
tripping (Blaya & Herr, 2004). It also inhibits the ability to make initial contact (IC) with the 
heel at the start of stance (Leung & Moseley, 2003) making this transition less stable and 
smooth, which also reduces stability. These two factors can restrict the person’s motivation, 
confidence and ability to walk in their own environment.   
Given its prevalence and impact, the foot-drop impairment is of clinical importance and any 
intervention that can address it warrants investigation. The most commonly used 
interventions to address foot-drop are physiotherapy, botulinum toxin, surgery, orthotics 
and functional electrical stimulation (FES).  This thesis focuses on the two most common 
devices to correct foot-drop; orthotics and FES. 
 
1.3 Ankle Foot Orthoses 
Orthotics, most commonly ankle-foot orthoses (AFO), are the most frequently used device 
for foot-drop (Bosch, Harris & Wing, 2014). AFOs are externally applied devices that add 
stiffness to the ankle joint complex thereby controlling its motion and alignment (National 
Health Service (NHS) Quality Improvement (NHSQIS) Scotland, 2009). The mechanical 
properties of an AFO, notably stiffness (Bregman et al., 2010; Bregman et al., 2011), can be 
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manipulated through the geometry of the device and choice of materials during the design 
stage to achieve the desired outcome. There are a range of AFO designs (NHSIQ, 2009). 
Posterior leaf spring and hinged AFOs address foot-drop caused by anterior compartment 
musculature weakness but may not address any associated medio-lateral instability or over 
activity in the triceps surae complex (NHSIQ, 2009). Unlike posterior leaf spring AFOs, 
hinged AFOs allow tibial progression through stance supporting a more typical gait pattern. 
However, a hinged AFO cannot be used if there is inadequate length in gastrocnemius, as 
this will limit knee extension (NHSIQ, 2009). Solid AFOs, and ground reaction AFOs 
(derivatives of solid AFOs), provide medio-lateral stability and are indicated when foot-drop 
is caused by over activation of the triceps surae complex, as opposed to DF weakness. 
Ground reaction AFOs can also alter knee moments during gait, which may be beneficial in 
certain cases. The choice of which to use and how to customise the AFO to the individual 
user should be made by an orthotist (NHSIQ, 2009) following a detailed assessment, with 
the aim to provide external plantigrade support to help with foot clearance and stability 
during stance  (Mulroy, Eberly, Gronely, Weiss, & Newsam, 2010) by altering the 
biomechanics of the whole lower limb. AFOs have been shown to statistically increase DF at 
IC as well as increasing peak DF during early stance, toe off and swing (Tyson, Sadeghi-
Demneh, & Nester, 2013); although it should be noted that peak DF through swing does not 
accurately capture either toe or foot clearance.  Wearing an AFO during walking influences 
not only the ankle but also the more proximal joints in the lower extremity (Karandikar & 
Vargas, 2011). With regards the knee AFOs have been shown to increase flexion at IC, 
increase peak flexion during the loading response of the stance phase and improve peak 
extension in stance phase (Tyson et al., 2013). No statistically significant kinematic effects 
have been observed at the hip. AFOs have also been shown to facilitate weight bearing over 
the paretic leg during stance (Tyson et al., 2013). 
It is also accepted that reducing or eliminating the foot-drop impairment by wearing an AFO 
then allows for an increase in repetitive task-specific activity, walking, which is accepted as 
causing functional improvement (Langhorne, Coupar, & Pollock, 2009; National Institute of 
health and Care Excellence (NICE), 2014; Intercollegiate Stroke Working Party, 2016). The 
link between repetitive task-specific activity and functional improvement assumes 
neuromuscular plasticity, in which cells are able to phenotypically change in response to 
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changes in their state or environment (Brown & Hardman, 1987, as cited in Laidler, 1994). 
This process is experience-dependent (Kleim, 2011; Kleim & Jones, 2008) thus increased 
repetition of a specific functional task such as walking firstly results in short-term increased 
excitation of the nervous system, specifically the motor cortices and corticospinal tract 
(Thompson & Stein, 2004), and through longer-term repetition can result in genetic, 
synaptic, neuronal, spinal, cortical, muscular and skeletal structural changes. Any 
intervention that induces such changes is said to be working therapeutically (Dunning et al., 
2013). 
Until the 1960s callipers made from metal and leather (Figure 2) were the only widely used 
orthotic intervention for foot-drop (Condie, 2008).  
 
 
Figure 2: A Victorian child’s shoe and leg calliper in leather and steel by The Wellcome 
Collection is licensed under CC BY 4.0 
In the late 1960s, with the advent of thermoplastics (Condie, 2008) and complaints about 
issues such as appearance, weight and shoe choice difficulties (Ofir & Sell, 1980) there was a 
move away from metal and leather versions to plastic alternatives; which are largely still 
used today. 
AFO users report a number of benefits from using their device including ease of walking, 
increased independence, greater stability and increased confidence (Bulley et al., 2014; 
Leung & Moseley, 2003; Tyson & Thornton, 2001), but there are recognised limitations of 
AFOs reported by users. Some of these limitations relate to usability, which is defined by 
International Standards Organisation 9241 as the “extent to which a product can be used by 
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specified users to achieve specified goals with effectiveness, efficiency and satisfaction” 
(Arthanat, Bauer, Lenker, Nochajski, & Wu, 2007; Choi & Sprigle, 2011). The commonly cited 
usability limitations for AFO devices vary (Holtkamp, Wouters, van Hoof, van Zaalen, & 
Verkerk, 2015)  but have been broadly categorised as: 
1. Health which includes pain, chafing and skin damage 
2. Product such as dimensions, weight, size, adjustability 
3. User practice relating to aspects such as cosmesis, effectiveness and ease of use 
4. Functionality which includes hygiene, handling and freedom of movement (Holtkamp 
et al., 2015) 
These issues can result in dissatisfaction (Holtkamp et al., 2015) which has qualitatively been 
reported as potentially leading to reduced compliance (Bulley et al., 2014; Bulley, Shiels, 
Wilkie, & Salisbury, 2011; Holtkamp et al., 2015; Vinci & Gargiulo, 2008). Whether reduced 
compliance actually occurs has not been objectively evaluated, to the candidate’s 
knowledge but Holtkamp et al. (2015) reported that approximately 6.7% of 211 people who 
had an AFO prescribed to them, self-reported not using their AFO at all. 
The other commonly cited AFO limitation relates to the restriction to the available range of 
ankle movement (Hesse, Werner, Matthias, Stephen, & Berteanu, 1999; Leung & Moseley, 
2003). Mechanical requirements from an AFO vary over the gait cycle and hence passive 
devices, whose properties are fixed, are inherently limited (Blaya & Herr, 2004). The passive 
control exerted by the AFO will result in a limitation of further range of movement (ROM) 
into plantarflexion (PF) and, with the exception of some hinged AFOs, further DF. This 
means that a conventional AFO will always tend to bring the foot back to its neutral 
orientation and hence may take over from the DF muscles during swing and early stance 
phase; as well as opposing PF muscles used in push-off at the end of stance. This has been 
assumed to result in disuse effects leading to a worsening in the existing loss of volitional 
muscle activity which also leads to negative central neuroplasticity (Geboers, Drost, Spaans, 
Kuipers, & Seelen, 2002). These effects may partly explain users’ reports that gait feels 
“non-normal” and that there is a sense of reliance on the device (Bulley et al., 2014). 
Objectively there is mixed evidence to support these claims with some studies showing an 
immediate reduction in Tibialis Anterior (Tib Ant), a key ankle dorsiflexor, muscle activity 
(Crabtree & Higginson, 2009; Hesse et al., 1999; Lairamore, Garrison, Bandy, & Zabel, 2011; 
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Lam, Leong, Li, Hu, & Lu, 2005; Romkes, Hell, & Brunner, 2006). However no further 
reduction has been found following continued use (Geboers et al., 2002) and a meta-
analysis in this field was unable to draw inferences regarding the overall effect on muscle 
activity due to an inability to pool suitable studies (Tyson et al., 2013).  
Whether the assumption that the mechanism-of-action is simply immediately orthotic 
and/or that long-term use results in negative neuromuscular effects has influenced the 
focus for research in this field is unclear. However, it is clear that research has almost solely 
focussed on studying the effects of AFOs whilst they are worn; most commonly on a single 
day (Tyson & Kent, 2013; Tyson et al., 2013). These primary studies have informed a number 
of CNO disorder specific guidelines that recommend AFOs as an appropriate interventional 
device for foot-drop management (NICE, 2013; NICE, 2012; NICE., 2014; Intercollegiate 
Stroke Working Party, 2016; Scottish Intercollegiate Guidelines Network (SIGN), 2010) 
reporting AFO efficacy in increasing walking speed, reducing energy expenditure, improving 
spatial gait features (step/ stride length/ symmetry), increasing cadence, improving 
functional mobility (Modified Emory Functional Ambulation Profile (mEFAP) and Functional 
Ambulation Categories (FAC)) and normalising foot positioning at IC and toe-off. Although 
these are measures appropriate for evaluating effects on walking (Mudge & Stott, 2007) 
what they do not directly capture are the effects of the AFO on the foot-drop impairment 
during swing, where arguably the greatest impact of the impairment on the gait cycle is 
seen, nor do they explore the claim about the effect on volitional muscle activity. The single 
day crossover design primarily used by these studies preclude evaluation of whether AFOs 
are actually used following prescription, and/or how much walking a person does (rather 
than reports doing) outside of the lab.  There has also been no evaluation in these studies of 
whether those provided with an AFO are satisfied with the usability of their device once it is 
taken home. As such the specific impact of AFOs on the foot-drop impairment and the AFO 
user is unanswered by current guidelines; which limits discerning prescription. 
Alongside primary studies one systematic review was used to inform current AFO guidelines 
(Tyson & Kent, 2013) but in total four systematic reviews have explored the effects of AFO 
for foot-drop, caused by stroke (Dunning et al., 2015; Ferreira et al., 2013; Tyson & Kent, 
2013; Tyson et al., 2013). Two of these performed meta-analyses (Tyson & Kent, 2013; 
Tyson et al., 2013). Statistically and narratively these reviews collectively reported that as 
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soon as AFOs are worn there are observed increases in walking speed (although it does not 
meet the minimal clinically important difference (MCID) (>0.1 metres per second) (O'Dell et 
al., 2014)), increased step and stride length, improved functional ambulation, better balance 
(as determined by postural sway and weight transference), reduced energy cost and 
improvements in DF at necessary points of the gait cycle and knee range of movement.  
Somewhat surprisingly, given the uncertain effects on long-term changes to the 
neuromuscular system, Dunning et al’s (2015) narrative synthesis (Grant & Booth, 2009) 
also reported that AFOs have a positive long-term effects on walking speed, timed up and 
go (TUG), mEFAP, balance, functional exercise capacity (six minute walk test) and Quality of 
Life (QoL) both with and notably without wearing the AFO following a period of use. The 
reasons why a therapeutic effect was observed was not discussed by the authors, although 
they did note that the studies were likely underpowered, so the results should be viewed 
cautiously. 
With the exception of Dunning et al. (2015) the other three systematic reviews were 
primarily based on non-Randomised Controlled Trials (RCT). Tyson and colleagues (Tyson & 
Kent, 2013; Tyson et al., 2013) reported that RCTs were included but their findings were 
based on single group crossover studies, limiting the strength of their conclusions (Oxford 
centre for evidence-based medicine, 2009). Dunning et al. (2015) findings, while RCT based, 
are inconclusive due to methodological flaws in the review. Primarily these flaws related to 
the broadness of the comparisons made, which attempted to synthesise different 
interventions, using different evaluation measures whilst exploring different device effects; 
this prohibited meta-analysis. 
Therefore, whilst these reviews are able to suggest that AFOs impact on a wide range of 
evaluation measures both immediately, following a period of use and without them being 
worn they are unable to advance current clinical guidelines. This is because their findings 
are inconclusive and they do not further comment on AFO mechanisms-of-action or if/how 
AFOs are used outside of a laboratory setting. 
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1.4 Functional Electrical Stimulation  
The alternative interventional device for foot-drop is FES.  FES has been defined as: 
“the long-term or permanent use of an electrical stimulus to initiate and maintain a 
physiological response to supplement or replace an impaired or lost function. 
Although with the passage of time it may help in recovery that is not its objective 
(National Research Council, 1973, p. 78)” 
In the case of foot-drop FES this, usually, supplements or replaces impaired function of the 
musculature innervated by the common peroneal nerve. Stimulation is typically applied 
near to where it bifurcates into its deep and superficial branches (Stewart, 2008) with the 
aim of eliciting DF with appropriate levels of eversion so the foot clears the floor during 
swing. This stimulation is introduced and reduced gradually, referred to as rising and falling 
ramps, to limit eliciting spasticity (Singer, 1987) and mimic the eccentric control of the DF 
muscles during early stance; aiding a smoother transition from swing to stance. Although 
there is limited evidence of the effects on gait, when worn as an orthotic FES has been 
shown to positively influence the kinematics of the ankle; increasing DF at IC (Heller et al., 
2013; van der Linden, Hooper, Cowan, & Weller, 2014) during swing (Heller et al., 2013; van 
der Linden et al., 2014; Voigt & Sinkjaer, 2000) and at toe off (Voigt & Sinkjaer, 2000). 
However no other consistent effect on joint angles has been found (Voigt & Sinkjaer, 2000). 
Power generation during stance at the ankle, knee and hip has also been shown to 
significantly increase with FES (Voigt & Sinkjaer, 2000). As with AFOs regardless of 
mechanism the remediation of the foot-drop impairment allows the potential for increased 
task-specific repetitive activity (Langhorne et al., 2009). However in contrast to the 
literature on AFOs, in addition to this mechanism-of-action, some effects of having used FES 
have been observed after it was removed (Liberson, Holmquest, Scot, & Dow, 1961). This 
observation was referred to as carryover and assumed to be transient (Liberson et al., 1961; 
Moe & Post, 1962). Subsequently it has been recognised that the transient carryover effect 
is the impact of increased cortical excitation (Thompson & Stein, 2004) but that long-lasting 
therapeutic benefit can also occur as a result of FES use which is hypothesised to occur due 
to structural plasticity at spinal, cortical and muscular levels. This is turn is thought to result 
in positive effects on volitional muscle activity. The hypothesised mechanisms are: 
17 
Post device use 
 Spinal: A single pulse of electrical stimulation applied to a motor axon between the 
muscle and the anterior horn cell produces a pair of action potentials, one travelling 
orthodromically (to the muscle), to produce the desired movement, the other 
antidromically (to the spinal cord/ anterior horn cell) (Crago & Makowski, 2012). 
This, if combined with volitional effort (descending tract action potential), has been 
hypothesised to strengthen the modifiable Hebbian synapses within the spinal cord 
(Rushton, 2003). .  
 Cortical: FES stimulates sensory as well as motor neurons (Quandt & Hummel, 2014) 
resulting in increased potential for sensori-motor integration which will be processed 
centrally and has been shown to cause plastic changes (Everaert, Thompson, Chong, 
& Stein, 2010). 
 Muscular: Peripheral stimulation causes increased oxidative capacity, increases 
micro-capillaries and changes muscle fibre type (Kluding et al., 2013).  
These possible positive mechanisms-of-action have led researchers to consider whether FES 
devices could also be used as a short-term interventional device to positively influence 
UMNS features such as weakness and spasticity (Burridge, Taylor, Hagan, Wood, & Swain, 
1996; Glanz, Klawansky, Stason, Berkey, & Chalmers, 1996; Glinsky, Harvey, & Van Es, 2007; 
Sabut, Sikdar, Kumar, & Mahadevappa, 2011) and functional outcomes such as walking 
speed and functional exercise capacity (Dunning et al., 2015; Robbins, Houghton, 
Woodbury, & Brown, 2006).  
This consideration has led to the recognition of a number of possible device effects (Figure 
3). In recent AFO-FES comparison studies testing for some of these effects has also been 
investigated. 
 
Figure 3: Possible device effects (FDS=Foot Drop Stimulation). Adapted from Dunning et al. 
(2013) with continuing orthotic effect (Miller et al., 2017; Street, Taylor, & Swain, 2014) and 
 Continuing orthotic 
effect 
 
Without AFO or FES 
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sustained therapeutic effect (new term proposed by Prenton, Hollands, Kenney & 
Onmannee, 2018) added. 
These device effects can be summarised as follows: 
1. Immediate (orthotic) effects: evaluations conducted before the device is provided 
and compared the evaluations conducted immediately after it has been provided, 
whilst the device is being worn (Dunning et al., 2013). Both evaluations are carried 
out on a single day. 
2. Continuing/Ongoing orthotic effects: evaluations conducted with and without device 
being worn at a given time point following a period of use (Miller et al., 2017). Both 
evaluations are carried out on a single day. 
3. Combined/ Total orthotic effects: evaluations conducted before the device is 
provided and compared to evaluations with the device being worn at a given time 
point following a period of use (Everaert et al., 2013) 
4. Training effects: evaluations conducted with the device being worn as soon as it has 
been provided and compared to evaluations again with the device being worn at a 
given time point following a period of use (Dunning et al., 2013) 
5. Therapeutic effects: evaluations conducted before the device is provided and 
compared to evaluations without the device being worn immediately following a 
period of use (Dunning et al., 2013) 
6. Sustained therapeutic effects: evaluations conducted before the device is provided 
and compared to evaluations without the device being worn at a given time point 
after the device is no longer used. These effects have been first described by the 
candidate in Article 6 of this thesis (Prenton et al, 2018). 
The first record of “Functional Electrotherapy” was published by Liberson et al. (1961) and 
the first commercially available system was the Ljubljana functional electrical peroneal 
brace (Figure 4) in the early 1970s (Condie, 2008; National Research Council, 1973). 
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Figure 4: Ljubljana Functional Electrical Peroneal Brace. From (National Research Council, 
1973) 
The first partially implantable version was reported in 1975 (Waters, McNeal, & Perry, 
1975). The change from stance to swing (and swing to stance) was detected by a heel (tape) 
switch which allowed activation (and deactivation) of the stimulation (National Research 
Council, 1973). Since that time this approach has not changed significantly with most 
systems still using a form of footswitch; although other gait event detection options are now 
available (Melo, Silva, Martins, & Newman, 2015). Appropriately trained clinicians currently 
have access to surface foot-drop FES systems from five manufacturers: Odstock Medical 
LtdTM; BionessTM; Innovative NeurotronicsTM; OttobockTM and Shenzen XFT Electronics Co., 
LtdTM. Previously two partially implantable FES devices were on the market, Odstock 
Medical LtdTM (STIMuSTEP®) and OttobockTM (Actigait®), but these are no longer 
commercially available. 
As with wearers of AFOs, FES users report that the positive effects such as reduced trips and 
falls, increased participation and capacity to walk longer distances outweigh any negatives 
(Bulley et al., 2014) but FES users also report usability issues (Bulley et al., 2014). These 
include discomfort caused by stimulation, skin irritation, the bulk of FES devices, the reliance 
on footwear (if using a footswitch), and problems with trailing wires sometimes used to 
connect the individual components (Bulley et al., 2014; Bulley et al., 2011). The most 
common complaint amongst users, cited by 44% (Taylor, Burridge, et al., 1999a), relates to 
difficulty in electrode placement. As previously stated stimulation, via the active electrode 
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(cathode), should typically be placed over where the common peroneal bifurcates into deep 
and superficial branches (Stewart, 2008). The more posterior nerve (the superficial peroneal 
nerve) innervates the peronei muscles which evert and PF the foot whereas the more 
anterior deep peroneal nerve innervates the Tib Ant, as well as the toe extensors, which DF 
and invert the foot. In order to get an acceptable foot response, it is therefore important 
that each individual user knows how to place electrodes correctly and to recognise what is 
an acceptable foot response. Odstock Medical LtdTM, the largest UK FES manufacturer, have 
developed an instruction sheet detailing how to accurately place both electrodes (Appendix 
2). As can be seen this is not always easy to achieve especially given the variation in 
individual anatomy and clinical presentation; which can also vary day-to-day. It relies on the 
user to have sufficient dexterity and cognition to achieve satisfactory placement, both of 
which can be impaired by CNO disorders. This coupled with inaccuracies in user perception 
of when they have achieved a satisfactory foot response, which is influenced both by 
electrode placement and amplitude of stimulation, results in setup being a significant 
usability issue with FES devices (Heller et al., 2013; Prenton, Kenney, Stapleton, et al., 2014). 
Despite the comprehensive education and support provided by many of the manufacturers, 
which may address these issues for a large percentage of the population, this can also 
undermine the efficacy of the device (Figure 5). These factors extend setup time, can 
present a barrier to clinical prescription (Roche & Coote, 2007) and can result in 
dissatisfaction. As with AFOs, whether these factors reduce daily compliance is unknown, to 
the candidate’s knowledge, but again as with AFOs self-reported discontinuation of use is 
low at approximately 10% each year (Taylor, Humphreys & Swain, 2013). In Taylor et al’s 
(2013) study only 1 directly reported electrode placement difficulties for why they 
discontinued with FES use, but 1 other reported finding it too much bother, another 4 found 
FES difficult to use and a final 5 found insufficient benefit from use (Taylor et al., 2013). 
These latter reasons were not expanded upon but it is possible that they may be, in part, 
related to electrode placement issues. It is worth noting that the 2013 paper reported data 
from the UK National Clinical FES Centre. It is possible that other centres in different 
regions/countries offer different levels of user training and support, which may in turn 
result in different levels of compliance. 
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Figure 5: Example of inappropriate electrode placement in a participant from Prenton, 
Kenney, Stapleton, et al. (2014) 
Manufacturers have sought to address the electrode placement issues by developing 
versions with leg-cuffs to house the electrodes, the location of which the clinician sets when 
prescribing. However, these do not allow for easy adjustment of electrode location to 
address individual or day-to-day variations nor can they address the issue of stimulation 
amplitude selection during setup. Partially implanted devices address some of these issues 
but at a greater cost and risk; hence the withdrawal of them from the market.  
There is a UK-wide guideline that specifically endorses FES (NICE, 2009) as an appropriate 
interventional device for foot-drop for all CNO disorders despite all-but-one included study 
(Taylor, Burridge, et al., 1999b) solely studying stroke. This guideline used a variety of 
primary and secondary sources to recommend that FES has positive effects on speed, 
energy cost (Physiological Cost Index (PCI)), exercise capacity, the ordinal gait scale by 
Tinetti, “functional milestones”, activity monitoring and the Fugl-Meyer assessment of 
motor recovery. This guideline is used as the basis for a National Stroke Guideline 
(Intercollegiate Stroke Working Party, 2016). As with AFO guidelines although these 
recommendations are based on evidence of effects the measures of evaluation are unable 
to determine how FES impacts the foot-drop impairment as there are no direct measures of 
if/how they affect the foot clearing the floor during swing, or from swing to stance, or what 
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effect there is on volitional muscle activity. Activity monitoring, which has been used by a 
small number of studies (Kluding et al., 2013; Kottink et al., 2007; Sheffler et al., 2015; Van 
Swigchem, Vloothuis, Den Boer, Weerdesteyn, & Geurts, 2010) might be assumed to 
capture task-specific repetitive activity but whilst the types of monitor used can distinguish 
between time spent in sitting/lying, standing and stepping (Godfrey, Culhane, & Lyons, 
2007) and/or the number of steps taken they cannot not distinguish between walking when 
the FES device is being worn and when it is not. Thus they cannot accurately capture this 
potential mechanism-of-action and as with AFOs, although shown to be effective, these 
studies are unable to report on whether individuals provided with an FES are satisfied with 
the usability of their device. One other guideline exists that mentions FES for the treatment 
of foot-drop caused by stroke (Scottish Intercollegiate Guidelines Network (SIGN), 2010). 
This guideline recommends FES use where the aim of treatment is the immediate 
improvement in walking speed and/or efficiency (PCI). 
Although a number of systematic reviews of FES include some foot-drop primary studies and 
meta-analysis (Glanz et al., 1996; Howlett, Lannin, Ada, & McKinstry, 2015; Pereira, Mehta, 
McIntyre, Lobo, & Teasell, 2012; Robbins et al., 2006), to the candidate’s knowledge, only 
four have been foot-drop specific (Dunning et al., 2015; Kottink et al., 2004; Miller et al., 
2017; Roche, o'Laighin, & Coote, 2009); three focus on stroke (Dunning et al., 2015; Roche 
et al., 2009) the other on MS (Miller et al., 2017). Of these only two were specific enough to 
afford meta-analysis (Kottink et al., 2004; Miller et al., 2017). All four of these reviews 
reported that FES has positive orthotic effects on walking speed and for those that meta-
analysed the improvement was found to be both statistically significant and, in contrast to 
AFOs, exceeding the MCID (O'Dell et al., 2014). Energy expenditure was reported to be 
reduced (Dunning et al., 2015; Kottink et al., 2004; Roche et al., 2009) and balance, TUG and 
functional exercise capacity improved with the use of an FES device (Dunning et al., 2015). 
However this was based on narrative synthesis only (Grant & Booth, 2009). Therapeutically  
Dunning et al. (2015) narratively reported that FES improves TUG, mEFAP, functional 
exercise capacity, balance and reduces energy expenditure (Dunning et al., 2015). 
Conversely Roche et al. (2009) found inconclusive evidence for any therapeutic effects and 
the meta-analysis by Miller et al. (2017) did not find a statistically significant therapeutic 
improvement in walking speed. Dunning et al. (2015) also reported that FES improved the 
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QoL for users. As with AFO systematic reviews here again it can be seen that whilst these 
reviews highlight positive effects of FES devices on appropriate walking measures they do 
not further our understanding of the mechanisms-of-action or whether provision leads to 
actual use outside of a laboratory, related to how usable the devices are. 
Additionally, with the exception of Dunning et al. (2015), and in keeping with the AFO 
literature these reviews were primarily based on non-RCT studies which limits the strength 
of their conclusions; and again Dunning et al. (2015) results are based on a focus that was 
too broad as to afford a statistical analysis. Therefore, similarly to AFO reviews whilst 
synthesised evidence exists it is not robust nor able to further develop our understanding of 
how FES works so cannot enhance current clinical guidance. 
 
1.5 Comparative Study  
Confusingly for clinicians both AFOs and FES for foot-drop are recommended to manage 
foot-drop but due to the way in which the devices’ efficacy have been evaluated the 
associated current guidelines cannot advise which is overall better/more effective; nor do 
they report on how the devices work, knowledge of which could help clinicians match a 
device to a person (Tyson et al., 2013).  
A body of evidence does exist which compares the two devices. These are either studies in 
which a single group of AFO users are then prescribed an FES device (Ring, Treger, 
Greundlinger, & Hausdorff, 2009; Schiemanck et al., 2015) those where the devices are 
randomly assigned test conditions on the same participant on a single day, to evaluate 
immediate orthotic effects only (Sheffler, Hennessey, Knutson, & Chae, 2009; Sheffler, 
Hennessey, Naples, & Chae, 2006), or are RCTs (Bethoux et al., 2014; Everaert et al., 2013; 
Sheffler et al., 2013).  
To date only one systematic review (Dunning et al., 2015) has had the potential to further 
clinical guidance as it synthesised comparative evidence focussing on RCTs alone (Howick et 
al., 2011). This review found between device comparability in terms of improvements in 
walking speed, TUG, mEFAP, Berg balance scale, functional exercise capacity, QoL and the 
lower limb Fugl-Meyer. But as previously stated, this review had too broad a focus, which 
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prohibited the meta-analysis expected when this level of evidence is synthesised. Emphasis 
was placed on which device participants would choose, with FES preferred, but this was only 
based on two studies (Everaert et al., 2013; Kluding et al., 2013) using unvalidated 
questionnaires. FES was also reported as being superior in reducing energy expenditure 
(PCI) but again this was only based on two studies (Burridge, Taylor, Hagan, Wood, & Swain, 
1997; Johnson, Burridge, Strike, Wood, & Swain, 2004) both of which did not compare FES 
to AFO. 
This review was the first to synthesise RCT level evidence and so was able to suggest for the 
first time that there is equal observed improvement in a variety of device effects, against 
many evaluation measures for both devices, but that despite this users prefer FES and 
require less energy to walk when it is worn. However, the conclusions are undermined by 
these flaws. Therefore, there is currently no robust comparative evidence to guide clinical 
prescription or enhance current guidelines. 
 
1.6 Gaps in the Evidence Base 
Based on this exploration of the knowledge base three clear gaps for the two foot-drop 
interventional Assistive Technology (AT) devices were identified. Firstly, limitations with 
device design. Advances in the materials used in AFO manufacturing and the technology 
around stimulator and electrode design afforded opportunities to address these limitations. 
The second issue is that although both devices have been shown to positively improve 
certain evaluation measures the measures chosen do not directly evaluate: the fundamental 
effects of the devices on the walking deficits caused by the foot-drop impairment; if the 
devices are usable and whether/how device prescription translates into actual increased 
levels of walking (with the device) in the user’s own environment.  
The third issue is that whilst clinical guidelines individually endorse both devices this 
guidance is based on sub-optimal sources with limitations in regards to how they have been 
evaluated. It is acknowledged that there are different types of AFO and FES systems. It is 
therefore likely to be the case that a particular device may be better suited to a certain type 
of user than another. However, in practice clinicians have limited time and cannot explore 
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all possible options for a given patient.  Therefore, guidelines as to the relative merits of 
AFOs compared to FES would help guide the prescription process. The only RCT comparative 
systematic review in the field (Dunning et al., 2015) does not report a statistical synthesis of 
the evidence and reported on similar evaluation measures to those used in the associated 
guidelines, so offers no further guidance in this regard.  
 
1.7 Body of Work Synopsis 
Prior to commencing the PhD an externally funded project had started to develop 
alternatives to recognised AFOs and FES to address some of the usability limitations that 
impact provision and compliance (Health Technology Devices (HTD) 480) including 
appearance, comfort and ROM restriction for AFOs and setup issues for FES. This group 
comprising engineers, an orthotist, nurses and (latterly) the PhD candidate (physiotherapist) 
recognised that user-involvement to design decisions would be a sensible approach. The 
description and evaluation of the co-design (lay advisors and researchers) process followed 
is provided in the first article. This article contributes to the rather limited evidence base 
concerning how to use such a group and the impact of their involvement on product and 
study design. 
The second article in the body of the work presented in this thesis explored the feasibility, 
preliminary efficacy and user views of an elasticated orthotic sock (DMO dorsiflex sock®) as 
alternative to an AFO designed to addressed some of the cited usability and ROM 
limitations. Unlike other work in the field it used an A-B single case experimental design 
(SCED) methodology (Ottenbacher, 1986)  with two stroke participants. Measures of gait 
symmetry, energy expenditure, walking speed, functional exercise capacity and FAC were 
utilised to preliminarily evaluate the efficacy of the device. A diary and a questionnaire 
(Tyson & Thornton, 2001) were also used to gather user views. The measures used spanned 
the three World health Organisation (WHO) International Classification of Functioning, 
disability and health (ICF) domains (WHO, 2001) and included a battery of measures that 
were clearly justified and, in some cases, novel (gait symmetry and the total heart beat 
index (THBI) as a measure of energy expenditure). This study was the first publication to 
look at this alternative to conventional AFO devices, with this population, in this way. 
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The third article is based on work that explored the feasibility (Arain, Campbell, Cooper, & 
Lancaster, 2010) and usability of an array-based FES device that used an automated setup 
process (ShefStim®). This device was the first to automate the setup process to address the 
cited electrode placement issues. An earlier prototype of the device had been shown to be 
effective in a laboratory based study (Heller et al., 2013). However, the Conformité 
Européenne (CE) approved device (ShefStim®) had not been previously studied. The study 
used a single-group of current FES users (Prenton, Kenney, Stapleton, et al., 2014). Careful 
consideration was given to the choice of evaluation measures used, in comparison to the 
participants own FES devices and no FES. Measures were chosen to: explore whether 
ShefStim® could be feasibly used outside of a laboratory; capture usability; directly capture 
the effects of ShefStim® on the foot-drop impairment to preliminarily explore the 
mechanisms-of-action and start to evaluate the impact on function. Three of these methods 
in this field were previously unused (Usage, foot clearance and a user satisfaction 
questionnaire (Demers, Monette, Lapierre, Arnold, & Wolfson, 2002)), indeed the foot 
clearance method was specifically adapted for this study. Other, more widely used 
measures (diary, kinematics at initial contact and walking speed) were also used. This was 
the first publication reporting on the real world evaluation of any FES system for foot-drop 
with automated setup. 
The fourth article reports on the design work leading to the development of ShefStim® 
(Kenney et al., 2016). The article cites and discusses the earlier ShefStim® article (Article 3), 
placing it in the context of the preceding design work. 
A phase III trial of ShefStim® (Medical Research Council, 2000) would have been a sensible 
next step following the demonstration of device and evaluation measure feasibility as well 
as a suggestion of worthy effect sizes (Article 3). However, it proved impossible to identify 
the commercial partnership needed to make the necessary product design changes and 
produce a larger number of stimulators needed for such a study. 
Through the empirical studies (Articles 2 and 3) it had become clear to the PhD candidate 
that: 
a) Some of the measures chosen for the two HTD480 empirical studies were not 
typically used in either the AFO or FES fields of research. The first use of foot-
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clearance as an outcome measure represents a clear advance for the field, which has 
previously relied on DF/PF trajectories, or toe-clearance to characterise how well the 
device achieves one of the key functions (ground clearance).  Further, the measures 
capturing use within the user’s own environment (logged usage, diary, donning/ 
setup times) and user satisfaction (face-to-face questionnaire, Quebec User 
Evaluation of Satisfaction with assistive Technology (QUEST) 2.0) also provided a 
novel perspective on these types of device. 
a) That the AFO and FES fields of research had been largely mutually exclusive until 
around the start of the PhD.  
b) Clinical guidance did not extend to which of the two AT interventional devices for 
foot-drop was better overall or how they worked. 
c) A number of RCTs comparing AFOs and FES had been conducted at the start of the 
PhD. 
As a result, the last two articles presented in the PhD (Articles 5 and 6) are two systematic 
reviews of RCTs, including meta-analysis, directly comparing the effects of AFO and FES on 
walking behaviours. 
The first systematic review (Article 5) focussed on their orthotic effectiveness following a 
period of use (Bosch, Harris & Wing, 2014). This review provided the first gold standard 
comparison (Howick et al., 2011) of the devices. It also drew attention to gaps in the 
knowledge base with particular reference to the comparison of the mechanisms-of-action. 
As rehabilitation aims to promote motor recovery (Langhorne et al., 2009; Levin, Kleim, & 
Wolf, 2009) the second systematic review (Article 6) compared the therapeutic effects of 
the devices. This was the first systematic review with meta-analysis in the area. Again it 
highlighted gaps in our understanding of the mechanisms-of-action and also the impact of 
the devices on the users’ participation in walking in their own environment. 
Although all the articles presented in this thesis sit within the realm of the two devices for 
foot-drop focussing on the three identified gaps in the evidence base there was a natural 
split in the focus. PART 1 focussed on evaluation of two new device designs aimed at 
addressing their cited limitations (Articles 1-4) and PART 2 compared the RCT evidence for 
AFOs and FES (Articles 5 & 6).  
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CHAPTER 2: PUBLICATIONS, including CRITICAL APPRAISAL 
PART 1 
2.1 Article 1 
Williamson, T., Kenney, L., Barker, A. T., Cooper, G., Good, T., Healey, J., Heller, B., Howard, 
D., Matthews, M., Prenton, S., Ryan, J., Smith, C. (2015). Enhancing public involvement in 
assistive technology design research. Disability and Rehabilitation: Assistive Technology, 
10(3), 258-265. doi: 10.3109/17483107.2014.908247 
2.1.1 Article 1 summary and publication 
This study sought to address the first identified gap in the evidence base by describing and 
evaluating the user involvement in the development of two new foot-drop devices. 
Users have reported limitations in foot-drop devices (Bulley et al., 2014; Bulley et al., 2011; 
Holtkamp et al., 2015; Taylor, Burridge, et al., 1999a) and the project team recognised that 
in order to match a new product with potential end users the device design development 
process would benefit from user involvement. This first article was based on a case study 
evaluation of the lay-advisory group that co-designed the new AFO and FES devices as part 
of the HTD480 project, alongside the device development/researcher team. The lay-advisory 
group comprised 10 individuals; five were current FES users and one was a past user of FES. 
By the end of the project there were six group members remaining. They met nine times 
over the course of the project (HTD480) and discussed the design of the devices and the 
design and evaluation measures of the two associated clinical studies. Each meeting had 
clear objectives set by the research team and were recorded for accurate documentation 
and interpretation.  
The evaluation involved interviewing both the researchers and lay-advisory group members 
at the beginning and end of the project; the lay-advisory group members were also 
interviewed at the mid-point. An a priori framework was developed to analyse the 
transcripts on these interviews. 
The evaluation highlighted that for lay-advisors benefits included increased confidence and 
feeling valued. They found the meetings to be well organised and the research to be 
engaging. The main issue raised related to parking challenges. 
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The results of the researcher group interviews highlighted a change in attitude from one of 
thinking the lay-advisors had little to offer to a realisation that lay-advisor contributions 
were invaluable with regards to product and clinical study development. 
The conclusions drawn related to how this article provides a model for public involvement 
that should help other AT researchers. 
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2.1.2 Candidate involvement2 
The candidate was not involved in the development of the National Institute for Health 
Research (NIHR) bid for the Health Technology Device (HTD480) project that proposed the 
use of a lay-advisory group. The candidate’s clinical experience led her to raise some issues 
with the proposed single clinical study which expected the participants to attend weekly 
data collection appointments over 18 weeks using a single case experimental design (SCED). 
The proposed weekly evaluation measures were walking speed; the six-minute walk test, 
falls diary, PCI, the modified Ashworth scale of spasticity (MAS) and activity monitoring; 
accompanied by “gait lab measurements”. The candidate’s questioning of the 
appropriateness of this approach had a key influence on what the lay-advisory group would 
input to with the candidate introducing and leading discussions pertaining to the attendance 
schedule and battery of measures. This resulted in changes being made to the subsequent 
studies (Articles 2 and 3). This is detailed within Article 1 and critically discussed in section 
3.1.3. The candidate was present at most of the lay-advisory group meetings and was 
involved in the researcher group interviews. Additionally, she contributed to manuscript 
review and feedback. This work was also presented at the INVOLVE conference in 2013 by 
the lead author, Tracey Williamson, and some members of the lay-advisory group (Appendix 
3a). 
2.1.3 Critical Appraisal 
User centred, inclusive or participatory design has been recognised as necessary if AT is to 
align with the needs and expectations of the user thereby avoiding inappropriately designed 
products (Wilkinson & De Angeli, 2014). The user-centred design approach has been applied 
to, amongst other products, the development of mobility aids, (Wilkinson & De Angeli, 
2014) wheelchairs (Sharma et al., 2008; Wilkinson & De Angeli, 2014) and environmental 
control switches (Dorrington, Wilkinson, Tasker, & Walters, 2016) but in the field of AT 
interventional devices for CNO foot-drop, despite user desire to be involved (Holtkamp et 
al., 2015) and devices not always meeting user needs/expectations (Holtkamp et al., 2015; 
Taylor, Burridge, et al., 1999a), if this approach has been used before it had not been 
published prior to the article. Purposive questionnaires have been used as post-market 
                                                          
2  A summary of the candidate’s involvement in each article is presented in Table 1 on page 5 
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surveillance (Taylor, Burridge, et al., 1999a; Taylor, Burridge, Dunkerley, Lamb, et al., 1999). 
Where this publication differs from other user-led non foot-drop design reports is that the 
process of the public involvement was evaluated and that the lay-advisory group, at the 
candidate’s suggestion, was able to contribute to the methodological decisions made for the 
associated empirical studies of the two new devices, as well as the design of the products 
themselves. 
The purposeful sample used to recruit the lay-advisory group was appropriate for the case-
study design (Marshall, 1996). The reported prevalence figures of foot-drop resulting from 
stroke (Verdié et al., 2004; Wade et al., 1987) suggested large numbers of potential 
participants from which to recruit to the empirical studies. It was only when the larger FES 
device study (Articles 3 & 4) was started that this was found not to be realistic. The reasons 
for this appeared to relate to a potential overestimation of foot-drop prevalence, certainly 
with regards foot-drop presenting in the absence of other significant impairments which 
excluded potential participants. This was coupled with local clinicians not engaging with 
recruitment citing time pressures and a lack of value placed on AT interventional devices in 
the context of physiotherapy. In line with the challenge of recruiting from the stroke 
diagnosis alone the candidate adjusted the recruitment strategy for the FES device 
evaluation study to include all CNO diagnoses. The impact of Article 1 basing all its results on 
stroke participants alone is unknown. The other potentially limiting factor in this regard is 
that only FES users were described in the article. As such despite some members trialling 
the new AFO device and commenting on its design it is unknown whether any of the lay-
advisory group had any previous experience of using an AFO or the impact of this. The study 
was also limited by a lack of discussion as to why there was a high participant attrition (40%) 
but there was sufficient data to meet the study aims.  
As the basis for the HTD480 project was to address cited limitations emphasis was placed on 
the extent and impact of the electrode placement issue. This resulted in the lead author 
over interpreting one piece of evidence (Taylor et al., 1999) by stating that some users 
found electrode placement issues to be a major problem, leading to long setup times and 
device abandonment. The Taylor et al (1999) study reported that 45% of past users cited 
electrode positioning problems as being either the primary (11%) or one of several (34%) 
reasons for discontinuing use.  However, the paper did not link electrode positioning 
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problems to setup time. The paper was based on postal questionnaires with a return rate of 
64% for current users and 43% for past users (Taylor et al, 1999).  
Overall the case study design and how it was evaluated was appropriate and reproducible. 
The utilisation of the lay-advisory group to guide how the two new devices were evaluated 
in terms of discussion around study design and measures used was conceptualised and led 
by the candidate which aligned closely with the Medical Research Council (MRC) guidance in 
the evaluation of complex interventions of a phase I study (Medical Research Council, 2000). 
The feedback provided by the lay-advisory group about these methodological aspects were 
pivotal in highlighting the need to study the feasibility of the SCED proposed in the HTD480 
project alongside the first, AFO, device (Article 2) as well as guiding the choice of evaluation 
measures which then led to the change in study design used to evaluate the new FES device 
(Article 3 & 4).  
 
2.2 Article 2 
Prenton, S., Kenney, L.P., Cooper, G. Major, M.J. (2014). A sock for foot-drop: A preliminary 
study on two chronic stroke patients. Prosthetics & Orthotics International. 38(5), 425-430. 
doi: 10.1177/0309364613505107  
2.2.1 Article 2 Summary & Publication 
This study was designed to fill the first two gaps identified in the evidence base. Firstly, it 
described an alternative to a conventional AFO device, designed to address cited 
limitations, and secondly aimed to evaluate the device using foot-drop specific and 
person-centred measures. 
The limitations cited for conventional AFOs relate to usability (Holtkamp et al., 2015) and 
potentially reduced volitional muscle activity (Crabtree & Higginson, 2009; Hesse et al., 
1999; Lairamore et al., 2011; Lam et al., 2005; Romkes et al., 2006) precipitated by ROM 
restrictions, both of which could result in user dissatisfaction. One solution to these 
limitations was an AFO constructed from a Lycra® like material (now marketed as the 
Dynamic Movement Orthoses (DMO) dorsiflex sock® by DMOrthoticsTM). This article reports 
on an evaluation of this elasticated orthotic device to establish its feasibility, gather user 
views, preliminarily evaluate its efficacy and evaluate the, revised, SCED design and choice 
41 
of measures that resulted from candidate direction and lay-advisory group involvement in 
the HTD480 project (Article 1). “The DMO Dorsiflex sock is designed to lift the foot up during 
walking and running (active dorsiflexion). This sock will improve incorrect walking patterns 
and provide additional uplift for patients with reduced strength” (DMOrthotics, n.d.). The 
principle suggested to achieve this is to introduce a net dorsiflexion moment through elastic 
panels that are stiffer on the dorsum of the foot/ankle as well as increasing proprioception 
(Gracies et al., 2000; Prenton, Kenney, Cooper, et al., 2014). This, is hoped, will remedy the 
foot-drop impairment, whilst at the same time the device addresses the usability limitations 
of appearance, poor comfort, restricted movement, and the associated, but largely 
unsubstantiated, claims of reduced volitional DF muscle activity, cited within the literature 
(Crabtree & Higginson, 2009; Hesse et al., 1999; Lairamore et al., 2011; Lam et al., 2005; 
Romkes et al., 2006). The manufacturer had been relying on an unpublished small (n=6) 
before-after study which focussed on sock use with children who had cerebral palsy which 
was published on their website (DMOrthotics, n.d.) but no evaluations on other pathologies 
had been undertaken. To explore the proof-of-concept of the DMO dorsiflex sock® the study 
undertaken by the candidate recruited two stroke participants as this was the most 
prevalent CNO diagnosis that had not been studied using such a device and there were 
potentially large numbers of potential participants from which to recruit. 
An A-B SCED (Ottenbacher, 1986) was used. In this design there is an A-phase when each 
participant is repeatedly evaluated without the intervention over a series of days/weeks 
followed by the B-phase whether the same number of observations are conducted over the 
same length of time but with the intervention being used. Each phase in the study 
undertaken by the candidate was four weeks with bi-weekly observations of the evaluation 
measures resulting in 16 data points, eight in each phase. The choice of this number of data 
points was guided by SCED literature (Ottenbacher, 1986).  
The second identified gap in the evidence base was considered in the context of their 
suitability and feasibility within the SCED with the original battery of measures in the 
HTD480 proposal first reviewed. The work by Brehm, Bus, Harlaar, and Nollet (2011) and 
Harlaar et al. (2010) as well as the WHO’s ICF (WHO, 2001) were also influential in guiding 
choices. These sources indicated that measures of body functions and structures (BFS) 
(WHO, 2001) were necessary if the mechanisms-of-action were to be determined as well as 
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measures that capture the functional effects of the device (Harlaar et al., 2010). 
Mechanisms-of-action measures were needed to build evidence to determine if/how the 
device works and whether the changes to the materials used to construct the DMO dorsiflex 
sock® preserved known mechanisms of AFOs on the fundamental effects on walking deficits 
caused by the foot-drop impairment. Functional measures were necessary to evaluate 
whether any mechanistic effects translated into meaningful outcomes for the user (Brehm 
et al., 2011). Functional measures were further sub-divided into capacity qualifiers (CQ) and 
performance qualifiers (PQ)(Brehm et al., 2011). The lower limb orthotic candidate core set 
developed by Brehm et al. (2011) was used alongside evaluation measure literature, the 
candidate’s clinical knowledge, lay-advisory group discussions and expertise within the 
research team to choose a justifiable battery of measures. Although the original set of 
measures in the HTD480 proposal covered the three ICF domains some of them were not 
deemed to be foot-drop specific or person-centred. As a result, some of the originally 
proposed, and commonly utilised, CQ measures were used (walking speed and six minute 
walk test), as was a variation of the user-perception measure (falls diary), but the BFS (PCI, 
MAS, “gait laboratory measurements”) and PQ measures (activity monitoring) were 
substituted for alternatives, following discussion with the lay-advisory group (Article 1). As 
recognised as part of the first identified gap in the evidence base participant views were 
also sought about the device and the study design. The success of the chosen evaluation 
measures is discussed in the critical appraisal of this article (2.2.3). 
Similarly, well-considered measures were lacking in previous foot-drop device evaluation 
literature. For example the proposed BFS measure that evaluates energy expenditure, PCI, 
tends to be collected over short distances (Burridge et al., 1997) this, coupled with the 
population being frequently physically unfit, means the steady heart rate needed to 
establish physiological cost is less likely to be achieved with the measurement protocols 
used. This invalidates such a measure (Danielsson, Willen, & Sunnerhagen, 2007). Similarly 
the MAS displays poor validity and reliability (Fleuren et al., 2010). Moreover, the candidate 
recognised that these commonly used measures, while allowing for study comparison, did 
not advance an understanding of whether there was any effect on the fundamental walking 
deficits caused by the foot-drop impairment nor whether there were discernible effects on 
user important outcomes. On reflection, activity monitoring would have added to the data 
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collected, albeit that it would not have indicated whether or not wearing the device was 
instrumental in any observed changes. It was discounted at the time due to concerns about 
whether participants’ had sufficient dexterity to use the monitors as well as concerns that 
the introduction of another device would overcomplicate the use of the sock.  
Electromyography would have also been an insightful addition to the battery of measures. 
This was not included due to a lack of knowledge on the candidate’s part at the time of how 
AFOs might influence volitional muscle activity. 
As a result the measures used to evaluate the device’s feasibility and efficacy were (Table 2): 
 Visit Number 
Evaluation measure 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Measures of body function and structure 
Trunk tri-axial accelerometry 
detecting vertical accelerations 
(step & stride regularity and step 
symmetry)  
                
Total Heart Beat Index (THBI) 
(energy expenditure) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Measures of functional capacity  
Average self-selected gait speed 
over six metres 
                
Six minute walk test (functional 
exercise capacity) 
                
Measures of functional performance 
Functional Ambulation Categories 
(FAC) 
                
Measures of user perception 
User opinion questionnaire (Tyson 
& Thornton, 2001) 
                
Diary recording donning/doffing 
time & any issues with use (1 day 
a week) 
                
End-of-study questions                 
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Table 2: Evaluation measures used in Article 2. A-Phase 
As stated in Chapter 1 the foot-drop impairment results in a slower speed and reduced 
endurance in walking. As such the evaluation of these frequently used aspects (Mudge & 
Stott, 2007) were deemed appropriate to evaluate. FAC is also frequently used (Mudge & 
Stott, 2007) and was chosen as the PQ alternative because it establishes a meaningful 
measure of mobility and was easy to administer (Williams, 2011). In contrast to the 
commonly used functional measures consideration of the most appropriate measures to use 
resulted in the chosen BFS substitute measures (THBI, trunk accelerometry) being novel in 
the field of research. Although the PCI has been criticised it was acknowledged that one 
potential mechanism-of-action of AFO, and the DMO dorsiflex sock® as a new iteration of 
this device, might be a reduction in the physical energy expenditure. The THBI (Hood, 
Granat, Maxwell, & Hasler, 2002) was chosen as a PCI alternative that was feasible within a 
SCED. An alternative measure for altered tone was not sought as the inclusion criteria 
required passive plantigrade to be achievable, thereby discounting potential participants 
with significant spasticity. The “gait laboratory measurements”, such as the kinematic 
and/or kinetic features of gait, proposed in the HTD480 project are frequently used 
measures within the BFS domain (Mudge & Stott, 2007) that can evaluate the mechanism-
of-action of a device on the transition from swing to stance, a key foot-drop walking deficit. 
However, gait laboratory based measures were logistically impossible to collect over the 
SCED bi-weekly, eight-week data collection schedule due to the lack of sufficient access to 
the University of Salford’s gait laboratories and the associated time commitment needed to 
analyse the resulting data. Therefore, alternative, more practical, measures were sought. 
Gait variability using a tri-axial lumbar accelerometer which used inertial sensors to detect 
vertical accelerations (Moe-Nilssen, Aaslund, Hodt-Billington, & Helbostad, 2010) was 
chosen. These determined step and stride regularity and symmetry as a function of these 
(Hodt-Billington, Helbostad, & Moe-Nilssen, 2008) without the need for a gait laboratory. 
The chosen user-perception measures, which considered the feasibility of the device, were a 
generic diary which was collected weekly during the B-phase to log donning/doffing times, 
use and any issues/effects experienced. This was used alongside the AFO questionnaire 
developed by Tyson and Thornton (2001) and end-of-study questions that collected 
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information pertaining to the participant’s views on the study design and chosen evaluation 
measures. 
Data analysis of objective measures was based on visual inspection of graphical 
representation and use of the 2-Standard Deviation (SD) method (Ottenbacher, 1986). This 
method calculates the mean of the A-phase and plots a 2SD band either side of this. This is 
extrapolated across the B-phase and, in the absence of autocorrelation, if two consecutive 
points sit outside of that band in the B-phase the result is said to be significant. Measures of 
user perception (Questionnaire, diary and end of study questions) were narratively 
reported. 
The study was able to report that the included participants found the DMO dorsiflex sock® 
feasible to use; this was the first time this had been shown for this population. It also 
highlighted that users perceived it to improve their walking. The study showed that the 
chosen and justified range of evaluation measures was feasible within the previously unused 
study design (SCED). Preliminary evaluation of these measures, that spanned BFS, CQ and 
PQ domains suggested that, in contrast to user-perception, objectively there were no clear 
effects. These findings concluded that the DMO dorsiflex sock® should be viewed with 
caution as an alternative to AFOs. 
Finally, it also helped to highlight, alongside the lay-advisory group, potential limitations 
with the methodologies chosen. Namely the challenges of recruiting a larger group of 
participants who could commit to attending the intensive evaluation schedule and the 
logistical challenges of timetabling all the necessary data collection appointments for that 
larger sample size. It also showed that, although clearly justified and appropriate within the 
SCED, a different study design might allow the evaluation of effects on measures that could 
more specifically capture the fundamental effects on walking deficits caused by the foot-
drop impairment. Thus this study influenced the methods used in the subsequent study 
(Articles 3 & 4). 
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2.2.2 Candidate involvement3 
The candidate was the driving force behind this study and its publication. The original 
HTD480 project had suggested the use of A-B SCED with weekly measures for the final work 
package (single evaluation study of both devices). The candidate questioned the 
appropriateness of this based on clinical knowledge of potential participant availability over 
extended periods and lay-advisor feedback. This was therefore refined by the candidate, 
with input from the lay-advisory group and extensive reading around this methodology for 
this initial study, as a pilot study to evaluate the proof-of-concept of the sock and to inform 
the final larger planned study. All measures were chosen and the majority of the data 
collection was done by the candidate. The manuscript write up, the journal chosen and the 
submission/ manuscript changes was led by the candidate. 
2.2.3 Critical appraisal 
Single case studies and case series had been used in the evaluation of FES devices (Burridge 
et al., 2007; Daly et al., 2001; Taylor, Burridge, et al., 1999b) before but this publication was 
the first within the AFO/FES field of research to use SCED. SCED is a clinically relevant 
alternative to experimental design (Barlow, Nock, & Hersen, 2009) that seeks to address 
some of the limitations with traditional group design. Of note group design relies on large 
representative randomised samples in order to address threats of internal and external 
validity. This is not always possible, especially within a heterogeneous population such as 
stroke (Todman & Dugard, 2010). Traditional group design also aims to statistically prove or 
disprove a hypothesis, based on group averages. This can be difficult to clinically apply to 
individual patients especially if they differ from those included. SCED addresses this by 
allowing focus on individual results (Barlow et al., 2009). Pragmatically the SCED approach 
allowed for a preliminary study of the DMO dorsiflex sock® without the need for extensive 
recruitment.  
This proof-of-concept study met its aims by showing that the device could be successfully 
implemented and credibly evaluated. As such it was able to comment on the 
appropriateness of further direct replication studies (Byiers, Reichle, & Symons, 2012) or a 
                                                          
3 A summary of the candidate’s involvement in each article is presented in Table 1 on page 5 
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more traditional phase II/III  trial (Medical Research Council, 2000) and indicate how this 
might be undertaken. 
With regards the SCED, the number of data points used in each of the two phases (eight per 
phase, 16 in total) was supported by SCED literature (Johnston & Smith, 2010) and the 
decision to make the visits twice weekly was made with lay-advisory group involvement to 
reduce the time commitment to the participants. Both participants attended all the sessions 
and 100% of the planned data was collected at each session. However, the design 
highlighted the logistical difficulties this schedule might pose with larger participant 
numbers. Alternative SCED were considered and discounted. Withdrawal (A-B-A) and 
alternating designs (A-B-A-B) assume there are no lasting carryover effects (Barlow et al., 
2009; Todman & Dugard, 2010), and whether these occur with this device was unknown. 
The feasibility of recruitment and participant compliance with the SCED design was also 
unknown which discounted the use of the multiple baseline design (Todman & Dugard, 
2010).  
As described, the measures used to evaluate the feasibility and efficacy of the DMO 
dorsiflex sock® were chosen following detailed consideration of relevant literature, 
consideration of the possible mechanisms-of-action and functional effects of the device, the 
practicalities of undertaking repeated measurements within an A-B SCED, how to explore 
device feasibility as well as candidate clinical experience and discussion with co-researchers 
and the lay-advisory group. The candidate did not constrain the choices with a desire to 
ensure they were comparable to other studies in the field resulting in a novel combination 
of measures that, importantly, were shown to be feasible. This innovative approach, 
coupled with the previously unused SCED, sets it apart from other work in the field. As 
indicated in the article this originality did mean that results were harder to compare to 
others but do advance the field by suggesting a different approach to study design and 
measure selection. With hindsight it became evident that the THBI & gait symmetry 
measures, whilst being easy to implement and capturing gait features in the BFS domain 
that could potentially indicate mechanisms-of-action, were not sufficiently foot-drop 
impairment specific. This allowed reconsideration of the evaluation measures used in the 
subsequent, larger, study and how that study was best designed to utilise those measures 
(reported in Articles 3 & 4). The chosen CQ measures (walking speed and six-minute walk 
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test) in conjunction with the SCED may have had a confounding effect of the results, 
particularly in the more impaired and probably least fit participant, participant 1. In this 
participant it was not possible to clearly distinguish the exercise/practice effects of 
participating in the protocol (twice weekly data collection visits each involving a six-minute 
walk and three nine metre walks) from any benefits of wearing the DMO dorsiflex sock®. 
This finding again allowed for re-consideration of how best to design the subsequent final 
study of the FES device (Article 3 & 4). 
The user-perception measures (diary, questionnaire, end-of-study questions) contributed to 
the demonstration of device feasibility. However, they also highlighted the tendency for the 
participants in this study to underestimate donning/doffing time, as what was observed 
when participants were in being evaluated did not appear to reflect the times reported in 
the diaries. These measures also suggested that subjective user-perception of improvement 
did not match with objective data. This again helped to inform evaluation measure choices 
for the subsequent study (Articles 3 & 4) as it highlighted that evaluative measures such as 
these introduced social desirability bias (Grimm, 2010). 
Visual inspection of graphically represented data is the most commonly used method to 
analyse SCED data, with debate as to the appropriateness of applying statistical testing to 
SCED, given its focus on the individual (Ottenbacher, 1986). However, to justify further, 
larger scale, study effect sizes need to be explored. The use of traditional parametric tests; 
randomization tests, autoregressive integrated moving average (ARIMA), interrupted time-
series analysis (ITSA), Revusky’s Rn, split middle/ celebration line technique, double boot-
strap, the 2-SD band method (Barlow et al., 2009) C statistic (Ottenbacher, 1986) and 
running median (Zhan & Ottenbacher, 2001) were researched. Traditional parametric tests 
are not appropriate for SCED as they violate the required assumptions (Barlow et al., 2009). 
Some of the SCED specific tests required too many data points (running median, ARIMA & 
ITSA), others required other SCED designs and randomization of when intervention is 
introduced (randomization; Revusky’s); the data showed an improving baseline for one 
participant in some of the outcome measurements which discounted the split-
middle/celeration technique and C statistic and the candidate could not find sufficient 
information about the double-boot strap method. The semi-statistical 2-SD band method 
was decided upon by the candidate to be the only appropriate approach (Ottenbacher, 
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1986) alongside the visual inspection of graphically represented data. A lag-1 
autocorrelation coefficient (rk) for the baseline was calculated (Bengali & Ottenbacher, 
1998) and the significance of serial dependency was calculated using Bartlett’s method 
(Bloom, Fischer, & Orme, 2003). Whilst more rigorous statistical methods could have 
provided greater strength of inference (Johnston & Smith, 2010) ultimately the design met 
the aims of the study of evaluating the feasibility of the DMO dorsiflex sock®, gathering user 
views, preliminarily evaluating the efficacy of the device and evaluating the credibility of the 
methods chosen. 
The two participants that were recruited, through local stroke groups, were both male with 
right sided hemiplegia of a similar age and ambulatory class (as determined by the FAC 
(Mehrholz, Wagner, Rutte, Meissner, & Pohl, 2007)) and neither were employed. This 
homogeneity could be seen as a threat to the external validity of the results. Conversely 
some would argue that the homogeneity could highlight direct replicability which 
strengthens the reliability of SCED findings to that specific part of the population (Barlow et 
al., 2009).  
With regards the device itself the mechanical properties were not reported nor was this 
reported in the article. This is now recognised as a limitation of all AFO evaluation studies 
(Bregman et al., 2010; Ridgewell, Dobson, Bach, & Baker, 2010) but was not considered at 
the time. However, given the nature of the elasticated materials used it is unlikely to be 
possible to report the mechanical properties of the sock in comparable way to conventional 
AFOs, which raises challenges for future studies.  
It is acknowledged that the conclusion drawn by this article that the DMO dorsiflex sock® 
should be cautiously viewed as an alternative to a conventional AFO is undermined by the 
limitations discussed above and therefore further study is necessary to substantiate the 
findings. However overall this study was able to demonstrate that a commercially available 
elasticated orthotic (DMO dorsiflex sock®) suggested as an alternative to conventional AFOs, 
to address their commonly reported limitations, could be feasibly used by stroke 
participants. However, that by addressing those limitations efficacy would be appear to be 
undermined; as shown by the negligible effect sizes on walking measures across the ICF 
domains. Moreover, this study has the potential to indirectly impact future clinical 
guidelines as it contributed an evaluation of a foot-drop device using a novel study design 
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(SCED) and a justified approach to the measure choice, thereby informing future study 
designs in this area. This study incorporated user/participant feedback to inform the design 
and evaluation of the device, from the lay-advisory group and participant perspective. The 
users’ feedback, as well as the consideration of the appropriateness the evaluation methods 
used within the SCED, in particular those that might specifically evaluate the fundamental 
mechanistic effects on walking were pivotal to how the next study was approached with 
regards design and measures chosen. 
 
2.3 Article 3 
Prenton, S., Kenney, L.P, Stapleton, C., Cooper, G., Reeves, M.L., Heller, B.W., Sobuh, M., 
Barker, A.T., Healey, J., Good, T.R., Thies, S.B., Howard, D., Williamson, T. (2014). A 
feasibility study of a take-home array-based functional electrical stimulation system with 
automated setup for current functional electrical stimulation users with foot-drop. Archives 
of Physical Medicine & Rehabilitation, 95(10), 1870-1877. doi: 10.1177/0309364613505107 
2.3.1 Article summary & Publication 
As with Article 2 this study sought to address both the first identified gap in the evidence 
base by looking at the feasibility of an alternative version of a conventional FES foot-drop 
device, designed to address cited limitations (electrode placement difficulties). It focussed 
on using foot-drop specific and user-important evaluation measures so as to address the 
second identified gap around limitations in device evaluation.  
The preliminary findings from Article 2 that it was feasible to collect and measure a range of 
evaluation measures supported by the literature as being necessary to capture effects but 
that the DMO dorsiflex sock® may not show effect sizes worthy of further definitive 
evaluation of efficacy meant that further study into this device was not deemed 
appropriate. The next, and final study, to come from the HTD480 project therefore 
investigated the FES device designed to address the setup limitation of conventional 
devices, called ShefStim®. The ShefStim® replaces the active electrode (cathode) with an 8x8 
array of 64 channels (Figure 6).  
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Figure 6: ShefStim® device showing the electrode array replacing the traditional cathode 
over the common peroneal bifurcation point. The conventional anode is shown in black. 
From Heller et al. (2013) 
Setup is automated, using a search algorithm to create 4x4 “virtual electrode” from that 
array. A phased approach which first detects the motor threshold required, then which 
virtual electrodes produce an acceptable foot response and finally ranks which of those is 
the most appropriate, based on a three-part cost function is used (Heller et al., 2013). This 
automation removes the reliance on the user to identify and perceive the correct, active, 
electrode position. The proof-of-concept laboratory based study of a ShefStim® prototype 
demonstrated that this prototype produced foot responses which were comparable to 
those produced by a clinician setup of a conventional FES system (Heller et al., 2013). The 
study was conducted with technical support on hand and with some of the setup process 
running on a computer. The product had been further developed, with consultation and 
input from the lay-advisory group, into the CE marked ShefStim® device. The next logical 
step was therefore to see if people could use this fully self-contained system in a real world 
environment. 
This study sought to evaluate the feasibility of using ShefStim® within a real world 
environment as well as to collect preliminary data regarding its usability (effectiveness, 
efficiency and satisfaction) (Arthanat et al., 2007; Choi & Sprigle, 2011)). Ten participants 
were recruited but three withdrew before it started resulting in a single group of seven 
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current FES users being studied. Participants were first evaluated with and without their 
own FES device being worn. They were then provided with a ShefStim® device, which they 
were shown how to use and then took home to use for two weeks. After which they were 
evaluated while ShefStim® was worn. 
The participant journey is detailed in Figure 7. 
Figure 7: Participant journey through ShefStim® study (Article 3). 
 
 
Foot-drop FES users expressed an interest
Screened against inclusion/exclusion criteria:
Inclusion:Unilateral foot-drop of CNO for at least 6 months; FES user 
for at aleast 3 months, 18yrs+
Exclusion: Having alternative treatment for foot-drop; unable to setup 
ShefStim; FES contraindications; unable to conset; unable to meet 
study protocol; unable to walk 5 metres
Visit 1: Evaluation of foot clearance, kinematics and speed 
with and without participants own FES device. Donning time 
captured and QUEST 2.0 completed for own device
Visit 2: Setting up and teaching of 
ShefStim® 
Home visit after about 1 week to 
replenish electrode arrays and answer 
queries
Visit 3: Evaluation of foot clearance, 
kinematics and speed with ShefStim. 
Donning time captured and QUEST 2.0 
completed for ShefStim®
End
Usage and Setup 
times logged by 
ShefStim® during 2 
weeks use. Diary 
used during this time 
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The evaluation measures used were: 
 Monitored ShefStim® Usage. The device logged the number of heel lifts as an 
approximation of the number of steps taken. This measure evaluated whether 
ShefStim® could be feasibly used and how much task-specific repetitive activity was 
engaged with.  
 Timed donning/automated setup for own FES device and ShefStim®. Whole system 
donning time was surreptitiously done when participants came for gait laboratory 
visits and the ShefStim® devices also recorded the time for each automated setup. 
The cited setup issues (Heller et al., 2013; Taylor, Burridge, Dunkerley, Lamb, et al., 
1999) extend the time of setup. The automation process employed by the ShefStim® 
was designed to reduce this and so whether this occurred was a necessary 
evaluation measure. This measure also explored the feasibility of ShefStim® use 
 Diary for the two weeks of use for the participants to record any external or setup 
issues they experienced, either completed by the participant or a carer. The diary 
again explored whether ShefStim® could be feasibly used outside of a laboratory 
environment in real time. 
 Foot clearance during swing based on the work by Sibylle Thies and colleagues 
(Thies, Jones, Kenney, Howard, & Baker, 2011; Thies, Kenney, et al. (2011)) to 
directly evaluate any effects on the foot-drop impairment. Figure 8 shows how these 
were setup prior to the arrival of the participant using a static capture. These were 
then removed and re-created virtually after data collection (Thies, Jones, et al., 2011; 
Thies, Kenney, et al., 2011). Ultimately only virtual markers P1, 2 and 4 (Figure 8) 
were investigated given that these most directly reflected the mechanical 
manifestation of the foot-drop impairment. The novel aspect in this study was that 
the positions of these virtual markers were analysed when they passed the 
contralateral medial malleolus. 
60 
 
Figure 8: Sole marker setup to evaluate foot clearance. From Thies, Jones et al., (2011); 
Thies, Kenney, et al., (2011) 
 3D kinematic gait analysis: sagittal and frontal plane ankle angles at initial contact 
(IC), to directly evaluate the effect on foot positioning from swing to stance, using 
the shank Calibration Anatomical System Technique (CAST) marker setup (Cappozzo, 
Catani, Della Croce, & Laeardini, 1995; Levine, Richards, & Whittle, 2012) alongside a 
shod foot model as seen in Figure 9 (Pratt, Reeves, van der Meulen, Heller, & Good, 
2012). Walking speed was also captured from an additional lumbar marker.  
 
 
 
Figure 9: Shod foot model.  From Pratt et al. (2012) 
 
 User satisfaction with own FES device and ShefStim®: The device sub-scale of the 
Quebec User Evaluation of Satisfaction with assistive Technology 2.0 (QUEST 2.0) 
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(Appendix 4) (Demers et al., 2002); which had not been considered by previous work 
in the field. 
Usage results showed that Shefstim® could be used unsupervised by all participants outside 
of a laboratory setting. The efficiency element of usability (Arthanat et al., 2007; Choi & 
Sprigle, 2011), as captured by donning/setup times, showed that although automated, and 
therefore not requiring effort or relying on perception on the part of the user, it took longer 
than expected. This was further noted as a problem by users in diary entries. As a feasibility 
study (Arain et al., 2010) the total setup time and diary results, alongside other reported 
setup and external issues, were useful for the further product refinement suggestions noted 
in the article (for example: user training material, voice commands, device charging). Not 
noted by users but recognised by researchers were the issues with the electrode-skin 
interface. The hydrogel used lost resistivity over time due to sweat ingress which could have 
led to transverse currents (Cooper et al., 2011). To combat this problem arrays had changed 
daily. This was neither clinically or commercially viable. Despite these reported issues 
participants were, overall, equally satisfied with both devices, as determined by the QUEST 
2.0; this was encouraging given the limited period of time it was used and its precommerical 
nature. 
Inferential statistics were not used but descriptive statistics indicated that the mechanisms-
of-action employed by conventional and ShefStim FES devices were comparable; with a 
suggestion of a better foot clearance during swing, as highlighted by the novel use of foot 
clearance as a foot-drop specific measure, and foot orientation correction at IC with 
ShefStim®, as indicated by ankle kinematics. The ShefStim device also had comparable 
effects on walking speed to conventional FES devices. These results indicated that the 
device, once the hydrogel issue had been solved, warranted a definitive efficacy trial, which 
would be required as an evidence base for prescription.  
Thus the study was able to conclude that the ShefStim was a feasible device that warranted 
further development work, followed by a definitive efficacy trial. It was able to achieve this 
due to the justified, and often novel use of the, battery of measures chosen.  
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2.3.2 Candidate involvement4 
This study was originally proposed to be an A-B SCED using stroke participants (with walking 
speed, six-minute walk test, PCI, MAS, falls diary and activity monitoring used as evaluation 
measures).  Article 2 highlighted that the logistics of running the study in this way were 
prohibitive both in terms of number of available potential participants and the practical 
logistics of repeated measure design if gait laboratory based measures were to be used. 
On the basis of experience and results from the first two studies the candidate redesigned 
this third study as a pre/post single group design focussing on device feasibility, device 
usability and measures that could specifically evaluate the fundamental effects on the foot-
drop impairment with recruitment encompassing any CNO pathology that had resulted in 
unilateral foot-drop. In accordance with the MRC guidance in the evaluation of complex 
interventions (Medical Research Council, 2000) the array FES device had passed through the 
pre-clinical (Kenney et al., 2015) and phase I/modelling phases (where components had 
been tested to develop an understanding of each and how they interrelate  (Cooper et al., 
2011; Heller et al., 2013; Pratt et al., 2012; Sha, Kenney, Heller, Barker, Howard, & 
Moatamedi, 2008; Sha, Kenney, Heller, Barker, Howard, & Wang, 2008; Williamson et al., 
2015). This study was a phase II trial (Medical Research Council, 2000) which sought to look 
at the feasibility of use outside of a laboratory and methods such as recruitment estimates, 
appropriateness of outcome measures to evaluate usability and an appropriate control 
group (Medical Research Council, 2000). Three visits over three to four weeks placed less 
burden on participants and, alongside the widened diagnoses, was hoped to improve 
recruitment and minimise attrition. 
The candidate initiated all procedures with regards NHS and University ethics, research and 
development liaison at various hospital trusts, recruitment, data collection, analysis and 
write up. The candidate also inputted into some aspects of design for example the 
suggestion to use an IPod holder as the foot pod (which housed the foot sensor and remote 
control device). The candidate took maternity leave during part of the study data collection 
period. On her return, part of this work was presented at the UK and Ireland FES symposium 
(UKIFESS) in Southampton that took place in 2013 (Appendix 3b). 
                                                          
4 A summary of the candidate’s involvement in each article is presented in Table 1 on page 5 
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2.3.3 Critical appraisal 
This small-scale feasibility (Medical Research Council, 2006) study was the first publication 
that showed that an array-based FES with automated setup can be used unsupervised in a 
“real” environment; as such it has ecological validity.  
 The length of study and the sample size were chosen based on pragmatic and budgetary 
constraints. Due to unforeseen technical challenges the HTD480 project ran significantly 
behind schedule restricting the available time, within the budget, to complete the 
evaluation of the system (final work package). Two weeks is a relatively short time to have 
studied the device however it was in keeping with acclimation periods in other studies (van 
Swigchem et al., 2011). The recruitment of current FES users also meant that the 
participants were not having to acclimatise to FES itself. The number of available ShefStim® 
units and array electrodes also influenced the study design. Without these externally 
imposed restrictions a longer study period and alternative study designs might have been 
considered. However, the equal improvements seen between the two FES devices 
suggested that two weeks was sufficient to meet the study aims of preliminarily 
investigating usage, satisfaction, setup times and effects. Two weeks was also sufficient to 
provide confident proof-of-concept results demonstrating that the ShefStim® device had 
effects on intended evaluation measures 
The candidate is confident in the choice of evaluation measures. Unlike the activity 
monitoring used in some studies (Kluding et al., 2013; Kottink et al., 2007; Van Swigchem et 
al., 2010) actual device usage indicates how many steps were taken whilst the device is 
worn. It cannot be constrained to one ICF domain as it shows actual participation in walking 
while simultaneously showing a potential mechanism-of-action (remediation of foot-drop 
leading to greater task-specific activity). Without the candidate’s consideration of the foot-
drop impairment and the concept of usability this measure might not have been chosen.  
It was recognised by the candidate that unless device usage was evaluated it would not be 
possible to quantify the dosage of either intervention a participant receives making 
understanding of mechanisms-of-action very difficult. Despite the clear potential to 
accurately track FES device usage this study was one of the first (Stein et al., 2010; Stein et 
al., 2006) to use the feature of some FES devices to collect steps taken and the first to report 
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individual participant’s results as well as group averages and to the candidate’s knowledge 
usage data has never been reported for AFOs. Reporting on the individual meant that the 
usage results were not only able to demonstrate ShefStim® proof-of-concept, as a feasible 
device within a home environment, but also highlighted that although task specific activity 
was engaged in by all participants there was large variation amongst the participants both in 
terms of the frequency and intensity of use. This resulted in very different “dosages” of 
ShefStim® FES stimulation for each person over the two-week period of use. The lack or 
sporadic use by some participants was discussed within the article as potentially being due 
to issues with ShefStim® use which were captured due to the decision to capture usability 
measures of efficiency and satisfaction. If device usage were to be used on a wider scale it is 
conceivable that observed results might differentiate between different patterns of use 
which could be correlated to user characteristics and user reported issues. This might 
ultimately help with more discerning prescription and/or product refinement. Further, 
combining such data with long-term generic activity monitoring would tell us the total 
activity levels, the types of activities engaged with (both captured by the generic activity 
monitor) and the amount of time a person chooses the device to walk compared to the time 
they choose to walk unassisted, calculated by subtracting the device usage data from the 
total activity level (activity monitor). More unassisted activity would indicate either less 
reliant on the device/improvement or a device usability issue. For FES this data could be 
viewed alongside the recorded setup parameters for FES providing a more accurate dosage 
estimation. This point was not discussed in the article as it detracted for the key take home 
messages plus it was not directly linked to the results found. 
Objectively timing donning and setup was evaluating a driving principle of ShefStim® namely 
that automated setup is easier for the user as it removes the requirement for electrode 
placement and determination of appropriate stimulation intensity. The ShefStim® prototype 
had found setup up time was less with the device compared to the participants own FES 
device; but this was compared to user self-reported times (Heller et al., 2013), a measure 
that the candidate had found to show poor accuracy in the DMO dorsiflex sock® study 
(Article 2). Therefore, neither traditional FES systems nor the ShefStim had not been 
subjected to objective scrutiny of setup times. Surreptitiously evaluating whole system 
donning time brought to light that some FES users of more than three months were 
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unaware of how to correctly don their system. Whether previous FES studies have relied on 
clinicians to don systems is largely unreported (Salisbury, Shiels, Todd, & Dennis, 2013) but 
there is a suggestion that this is the case. FES efficacy has been shown to vary depending on 
whether a trained clinician or the user setups up the system, with user setup being less 
efficacious (Heller et al., 2013). If the majority of current FES evidence is reporting results 
from clinician setup it could be overestimating FES effects. Logged automated setup times 
showed that, although user effort was not required, setup took considerably longer than 
expected. Recognition of this within the article allowed possible reasons for this to be 
explored which was helped by the use of the collected diary data to identify where product 
refinement was necessary.  
The chosen efficacy measures had face validity (Bloom et al., 2003) in relation to the 
fundamental deficits caused by foot-drop; namely trip risk caused by impaired foot 
clearance during swing (Begg, Best, Dell’Oro, & Taylor, 2007; Thies, Jones, et al., 2011) and 
poor foot orientation at initial contact which may also increase the risk of falls. DF at IC has 
been a key focus within some FES literature (Heller et al., 2013; Kottink, Tenniglo, de, 
Hermens, & Buurke, 2012; Meilahn, 2013; Voigt & Sinkjaer, 2000) but foot-clearance, which 
is arguably the primary purpose of a foot-drop device, had not been evaluated previously, 
although toe clearance was first reported by Kim, Eng, and Whittaker (2004). The difference 
between Kim et al’s (2004) evaluation of toe-clearance and our approach is that Kim et al 
measured only the minimal clearance of the fifth metatarsophalangeal joint during mid-
swing. Our use of virtual markers at different points of the sole of shoe takes into account 
that collision between the foot and ground may occur at points on the shoe other than the 
fifth metatarsophalangeal joint. Further, by capturing the location of virtual markers on the 
perimeter of the sole of the shoe it takes into account shoe shape, providing an accurate 
representation of shoe-floor clearance, rather than anatomical joint-ground clearance, as 
used by Kim et al. (2004). Ankle kinematics during swing have been reported on (Scott, van 
der Linden, Hooper, Cowan, & Mercer, 2013; Voigt & Sinkjaer, 2000) but are not a suitable 
substitute for clearance as they cannot indicate whether this reduces trip risk whereas toe 
clearance has been reported as crucial for safe walking and shown to relate to the 
probability and risk of tripping (Thies, Jones, et al., 2011). As such this study presented a 
unique insight into a fundamental FES mechanism-of-action. Since the completion of this 
74 
study the candidate has come to recognise that foot clearance within the participants own 
environment might have been captured with the use of inertial sensors (Dadashi et al., 
2014) and this approach is worth investigating in the future. Walking speed is one of the 
most commonly used measures of walking capacity (Mudge & Stott, 2007), its inclusion 
allowed for comparison to other studies in the field as well as it being shown that it is a key 
prognostic indicator (Studenski, Perera, Patel, & et al., 2011). The use of obstacle avoidance 
or step targeting, and/or carrying out a dual task whilst walking might have been more 
functionally relevant than walking speed alone, but the candidate was mindful of the length 
of visits for participants. The speed, kinematic and foot clearance results were reported to 
two decimal places which on reflection was inappropriate as this suggested a higher 
resolution of the measurement systems than was the case.  
The choice of some novel evaluation measures (usage, timed setup/donning diary in real 
time, QUEST 2.0, foot clearance) advanced the field of research by addressing the second 
identified gap in the evidence base. Prior to this study the focus within the literature had 
tended to be on laboratory measures of capacity (WHO, 2001) as the sole indicators of 
benefit (Prenton et al., 2016). This study moved the focus towards measures that evaluated 
potential relevant mechanisms-of-action, actual usage and usability. However, it restricted 
comparison with previous studies. Use of the more commonly used CQ measure of efficacy, 
walking speed, allowed for a comparison to previous studies; which were also clinically 
meaningful (Perera, Mody, Woodman, & Studenski, 2006). This was also true for the 
kinematics at IC. The similarity in the effect sizes described in this study with these other 
studies further supported the case that ShefStim® warranted a definitive efficacy trial, once 
the issue with the hydrogel array electrodes had been solved. 
The study therefore met its aims and would appear to have provided a case for a Phase III 
comparative trial (Medical Research Council, 2000). The results gave product development 
and user training guidance, with regards the voice command clarity on the remote control 
and the skip-site function that was not used by participants, to inform such a trial. However, 
the issue of the array electrode-skin interface meaning that new arrays were required daily 
was not resolved.  This, along with the lack of an appropriate commercial stimulator 
development partner meant that the device was not developed further at that time. Overall 
this article contributed to the knowledge base by using new and directly relevant 
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approaches to device evaluation. The study considered the fundamental deficits caused by 
foot-drop, addressing also the key issues of device usage and usability. This has the 
potential to impact the associated clinical guidelines if future studies in both the FES and 
AFO fields emulates this approach. 
 
2.4 Article 4 
Kenney, L.P.J., Heller, B., Barker, A.T., Reeves, M.L., Healey, J., Good, T.R., Cooper, G., Sha, 
N., Prenton, S., Liu, A. and Howard, D. (2016). A review of the design and clinical evaluation 
of the ShefStim array-based functional electrical stimulation system. Medical Engineering & 
Physics, 38(11), 1159-1165. doi: 10.1016/j.medengphy.2016.08.005 
2.4.1 Article summary and Publication 
This article sought to address the first identified gap in the evidence base (an alternative 
FES foot-drop device developed to address the cited electrode placement difficulties with 
conventional systems). 
 This article charts the design, development and evaluation of the ShefStim® FES device, the 
challenges that were faced, with particular reference to the design of the electrode array, 
the choice of hydrogel, the array search algorithm and how iterations of the device were 
tested first within a laboratory (Heller et al., 2013) and then in the community (Article 3). It 
reiterated what limited ShefStim® from being manufactured and studies on a larger-scale 
and suggested alternatives for the prohibitive electrode-skin interface problem. 
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2.4.2 Candidate involvement5 
The candidate’s central involvement  in the HTD480 project is reflected in articles 1-3. 
However, the candidate also contributed to  the review and feedback on this article (Article 
4) with particular focus on the fifth section, about the take-home ShefStim® device (page 
1164),  and the the associated part of the discussion and conclusions relevant to this study 
(page 1165) 
2.4.3 Critical Appraisal 
This article allowed readers to follow the development of the ShefStim®, provided context 
and explained key decisions. It brought together the articles that studied iterations of the 
device and explained how the ShefStim® device works and what the main results were. As 
such the reader has this information in one place with clear links to the associated articles 
and conference proceedings. In essence it shows compliance with MRC guidelines (Medical 
Research Council, 2000) by confirming that the pre-clinical, phase 1 and phase 2 have been 
completed, as well as presenting evidence of project completion the funding body 
(NIHR/HTD). 
The lay-advisory group (Article 1) and the DMO dorsiflex sock® (Article 2) were already in 
publication. Unlike the DMO dorsiflex sock® ShefStim® was a technological development 
explictly adhering to the MRC framework for trials of complex interventions (Medical 
Research Council, 2000). Therefore the article presents a technical narrative of the 
ShefStim®, including discussion around previously unpublished aspects of its development 
(Sha, 2008), which charts the progress to that point as well as aligning with the journal’s, 
engineering, focus. Publication focussing on device development allowed a detailed report 
of the ShefStim® device, which is important in evaluations of complex interventions 
(Medical Research Council, 2000, 2006).  Reporting the design, development and evaluation 
to date was also important given that further product development was indicated (by Article 
3) before further definitive (Phase III) efficacy testing could occur. So this article provides a 
detailed frame of reference to any researcher wishing to address these limitations and/or 
carry out efficacy evaluation once the product limitations have been overcome. This article 
therefore contributes an approach to how a new technology can be initally but 
                                                          
5 A summary of the candidate’s involvement in each article is presented in Table 1 on page 5 
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comprehensively developed and evaluated which, if adopted, could influence future clinical 
guidelines 
 
PART 2 
As stated in Chapter 1 the identified gaps in the AFO/FES foot-drop evidence base can be 
summarised as: 1) cited device limitations; 2) limitations in the evaluation of device effects 
and 3) a lack of good quality evidence with direct comparisons with which to further 
enhance clinical guidelines. The first of these gaps was addressed in PART 1 through 
development and early phase evaluations of devices; which used a lay-advisory group in the 
co-design of the products and the evaluation studies. The development of ShefStim® was 
further reported in Article 4 to fill that first gap. The clinical evaluation studies of the DMO 
dorsiflex sock® (Article 2) and ShefStim® (Articles 3) were conducted by the candidate in 
such a way as to try and address the second gap, for these devices. The unclear effects of 
the DMO dorsiflex sock® found in Article 2 and the difficult problem related to the electrode 
array-skin interface for ShefStim® highlighted in Article 3 meant it was not possible to 
proceed to definitive trial for either. However, through the empirical study of the DMO 
dorsiflex sock® and ShefStim® and via the process of giving attention to how to most 
credibly evaluate the devices in order to more fully explore their mechanisms-of-action, 
their usability and the functional translation into the users own environment it became 
apparent that: 
a) Some of the measures chosen for the two HTD480 empirical studies were not 
typically used in either the AFO or FES fields of research. The novel measures 
introduced in this thesis and which may be of value to the field include foot-
clearance methods, detailed characterisation of use outside of the lab 
environment (logged usage, diary, donning/ setup times) and user satisfaction 
(face-to-face questionnaire, QUEST 2.0) 
b) That the AFO and FES fields of research had been largely mutually exclusive until 
around the start of the PhD.  
c) Clinical guidance did not extend to recommendations on which type of device to 
choose, or how they worked. 
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d) A number of RCTs comparing AFOs and FES had been conducted at the start of 
the PhD. 
This part of the body of works therefore focussed on using the highest level of evidence, 
systematic review of RCT evidence with meta-analysis (Oxford centre for evidence-based 
medicine, 2009) to compare the orthotic and therapeutic effects of the devices on walking. 
The aim of the two reviews was to provide the highest level of evidence possible because 
any update in clinical guidelines would give greatest weight to RCT level evidence. Therefore 
Cochrane methodology of reviewing and meta-analysing was utilised (The Cochrane 
Collaboration, 2011). Given that national guidance about the devices has been applied to 
more conditions than just stroke (NICE, 2009; NICE, 2012; NICE., 2014; SIGN, 2013) there 
was a need for a synthesis of available evidence that included all CNO disorders. This meant 
that the work was not adoptable by a Cochrane review group which are organised according 
to single conditions (Stroke, Movement disorders and MS and rare diseases of the central 
nervous system). However their handbook (The Cochrane Collaboration, 2011; Higgins et al., 
2011) and the Preferred Reporting Items for Systematic reviews and Meta-Analyses 
(PRISMA) statement (Liberati et al., 2009; Moher, Liberati, Tetzlaff, & Altman, 2009) were 
utilised throughout for quality assurance purposes. Both reviews were registered with the 
International prospective register of systematic reviews (PROSPERO) for transparency, and 
to avoid any potential overlap. The candidate was mindful that a number of previous 
systematic reviews already existed. Most of these were focussed on one or other of the 
devices (AFO: (Ferreira et al., 2013; Leung & Moseley, 2003; Tyson & Kent, 2013; Tyson et 
al., 2013) and FES:(Kottink et al., 2004; Miller et al., 2017; Roche et al., 2009)). There was 
only one comparative RCT based systematic review (Dunning et al., 2015) which showed 
overall device comparability apart from preference which favoured FES but the breadth of 
the question asked by the authors prohibited meta-analysis and undermined its conclusions; 
as discussed in Chapter 1.   
It was therefore timely to try and make more robust clinical comparisons and to try and 
develop a clearer understanding of whether either type of device was more effective and 
also to see whether studies comparing the devices reported on how the devices work (their 
mechanisms-of-action) with the aim to guide clinical choice and inform future guidelines to 
seek to fill this third identified gap in the evidence base.  
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2.5 Article 5 
Prenton, S., Hollands, K., Kenney, L.P.J. (2016). Functional electrical stimulation versus ankle 
foot orthoses for foot-drop: a meta-analysis of orthotic effects. Journal of Rehabilitation 
Medicine 48(8): 646-656. doi: 10.2340/16501977-2136.  
 
2.5.1 Article Summary and Publication 
This article sought to fill the second gap in the evidence base identified by the candidate; 
that both devices lack foot-drop specific and user-important evaluation measures. It also 
sought to fill the third identified gap in the evidence base of a lack of clinical guidance 
about which device was better overall. 
This first review 
(https://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014009892) 
considered the devices as long-term orthotics which is how they are most commonly 
prescribed in clinical practice (Bosch, Harris, & Wing, 2014; National Research Council, 1973; 
Melo et al., 2015). As such the effects of interest were those which compared 
measurements with the device worn following a period of use to measurements taken at 
baseline while walking without the device (combined-orthotic effect (Figure 4)). Any 
measure of walking that captured this effect was considered and each measure was 
categorised according to the ICF domains of body functions and structures (BFS); 
activity/capacity qualifiers (CQ) and participation/performance qualifiers (PQ) (Brehm et al., 
2011; WHO, 2001). Relevant databases were systematically searched alongside key author, 
citation and journal searches. 1593 studies were identified of which seven met the inclusion 
criteria. These reported results from 815, stroke, participants who participated in five trials.  
Walking speed over ten metres (CQ); functional exercise capacity as determined by the six-
minute walk test (CQ); timed up and go (CQ) and perceived mobility as captured by the 
stroke impact scale (SIS) mobility sub-scale (PQ) were used consistently enough amongst the 
included RCTs that meta-analyses were possible. Regardless of when comparisons were 
made and despite the hypothesized mechanisms-of-action that may have predicted FES to 
achieve greater benefits over time (Prenton, Hollands & Kenney, 2016) the take home 
message was that the two devices had comparable, favourable, effects. This was the first 
time this had been quantitatively demonstrated. BFS measures of mechanisms-of-action 
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were limited to single studies so whilst there was suggestion of equal improvement in 
energy cost, the lower limb Fugl Meyer and cadence and FES superiority with regards 
temporal-spatial aspects of gait pattern nothing further could be concluded about what 
mechanisms both/either used to achieve the observed equal functional gains. Potential 
reasons for the observed equal improvement in capacity and participation were discussed 
with one suggestion being that it might be as a result of both devices remedying foot-drop 
leading to greater levels of task-specific repetitive activity, i.e. walking, which is recognised 
as a necessary approach to promote recovery (Levin et al., 2009); albeit in the absence of 
usage data to show this occurred. An alternative offered rationale was that the trials did not 
collect data over a long enough period to highlight any differentiation, especially given the 
chronic populations studied. 
Overall this article presented the first comparative meta-analysis of the two devices that 
was able to highlight, for the first time, their ability to produce statistically equal 
improvements in some activity and participation measures whilst simultaneously 
highlighting the failure of the RCT pool to evaluate how these improvements were achieved 
(mechanisms-of-action).  
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2.5.2 Candidate Involvement6 
The candidate led all key processes, from PROSPERO registration to all methodological 
decisions, journal choices, manuscript writing and re-writes. The candidate also prepared a 
poster detailing some of this work that was presented at UKIFESS 2015 in Sheffield 
(Appendix 3c). 
2.5.3 Critical Appraisal 
This was the first meta-analysis that used RCT level evidence alone focussed on a specific 
clinically relevant effect (combined-orthotic). It therefore provided a more precise and 
robust estimate of effect in the direct comparison between AFO and FES (Grant & Booth, 
2009). This along with the use of systematic searching, appraisal and synthesis using 
recognised good practice guidance (The Cochrane Collaboration, 2011; Liberati et al., 2009) 
gave confidence in the findings. The potential criticisms potentially levelled at this review 
article tie in with the limitations of the included RCTs, the decision to only focus on RCT 
evidence and walking measures and errors in the data extraction process.  
“A meta-analysis cannot be better than its included studies allow” (Grant & Booth, 2009, p. 
98). This systematic review included five trials, the results of which were reported in seven 
publications. These spanned a relatively short time span (2007-2015) with five of the seven 
publications, which resulted from four of the five trials, published within a two-year window 
(2013-2015). It could therefore be expected that trial authors were acting independent of 
each other, which might account for some of the common issues such as lack of evaluation 
measure justification and risks associated with bias that were found (i.e. that learning from 
each study could not be carried forward to improve the next). Conversely this shows that 
many authors identified that the need for RCT level comparison was necessary/timely at 
around the same period of time which, by extension, indicates the timeliness of this review 
article. 
The review highlighted the predominant use of laboratory based measures of capacity 
(WHO, 2001) to compare the AFO and FES devices with one trial lacking any BFS measures 
(Bethoux et al., 2015; Bethoux et al., 2014) and another not considering participation 
                                                          
6 A summary of the candidate’s involvement in each article is presented in Table 1 on page 5 
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domain/PQ measures (Everaert et al., 2013). Of those that did use measures that spanned 
the three ICF domains this framework alone was used in their justification of choices. With 
regards the lack of BFS measures, despite recommendations to include mechanistic 
measures (Harlaar et al., 2010), this is most likely explained by the fact that the primary aim 
of the included studies was not to determine the mechanisms-of-action. The lack of 
mechanistic alongside the lack of “real-world” evaluation measures did serve to further 
emphasise the second gap in the evidence base identified by the candidate; that both 
devices lack evaluations that would advance current clinical guidelines. 
Despite guidelines about how best to report mechanical properties existing for some time 
(Ridgewell et al., 2010), none of the selected RCTs reported any of mechanical properties of 
the AFOs used. As such their mechanical properties are unknown (Condie et al., 2004; 
Ridgewell et al., 2010) and hence cannot be accurately recreated in the future. A similar 
criticism could be levelled at the FES studies, in which only one of the selected trials 
reported set-up parameters. The potential device heterogeneity feeds in to the inability of 
clinicians to replicate interventions for which evidence is provided. However, it did make 
combining them a more realistic estimate of the effect seen across clinical services where a 
range of devices and setups are used. In recognition of this the review proposed how AFOs 
should be reported in the future; discouraging the sole reporting of either the materials 
used or mode of manufacture while encouraging reporting of mechanical properties 
(Bregman et al., 2010; Bregman et al., 2011). It also suggested that, alongside setup 
parameters, who sets up the FES device should be reported given the marked differences in 
performance that have been noted by the candidate and research group involved in the 
HTD480 project when a user sets up their FES device versus a clinician (Heller et al., 2013; 
Prenton, Kenney, Stapleton, et al., 2014).  
There is heterogeneity in clinical features amongst the stroke population (Louw, 2002). 
Large sample sizes, randomisation, a clear description of the participants according to 
appreciable subgroups and specific outcome measures address this by increasing the ability 
to generalise results (Louw, 2002). Although it is acknowledged that in relation to potential 
UK foot-drop population (approximately 240,000) the number of participants in this review 
was relatively small (n=815) it is very similar to the previous comparative review (Dunning et 
al., 2015) and larger than the device specific reviews (Ferreira et al., 2013; Kottink et al., 
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2004; Miller et al., 2017; Roche et al., 2009; Tyson & Kent, 2013; Tyson et al., 2013). As 
evidenced by the risk of bias assessment in Article 5 (page 650 of the article) random 
sequence generation appears to have been considered by some, but not all, of the included 
trials resulting in an increased risk of selection bias. The description of participants was 
generally limited, primarily including side of hemiplegia, chronicity, age and, in some cases, 
mental capability. Walking speed at trial entry was also focussed upon by three trials 
(Bethoux et al., 2014; Everaert et al., 2013; Kluding et al., 2013) Kottink et al. (2007) 
focussed on outdoors walkers, no further description was provided and Salisbury et al. 
(2013) only mentioned distance walk required (five metres). It cannot be concluded whether 
these aspects provide sufficient demarcation of the stroke population. The meta-analyses, 
via the I2 statistic, revealed that for some measures there was no significant effects of 
heterogeneity. Where there was heterogeneity this was accommodated for by using a 
random effects model. Until more good quality trials with adequate reporting of details this 
review therefore provided the best possible evidence to date.   
This review demonstrated that both devices had equal positive combined-orthotic effects 
on the activity/CQ measures of walking speed (over 10 metres) and functional exercise 
capacity (6-minute walk test) plus walking participation/PQ (SIS). This has not been 
comprehensively shown before this article and so is field leading. It is accepted however 
that the limited range of evaluation measures chosen restricted the conclusions that could 
be drawn and thus how clinical guidelines could be updated. Nothing conclusive could be 
said about the mechanisms-of-action as no numerical analysis of BFS measures could be 
undertaken. This was disappointing, but not completely unsurprising given that was not the 
primary aim of the included studies. 
Stroke is largest CNO population and importantly is not degenerative which might explain 
the tendency of researchers to focus on this population for participants. Research of the 
effects of AFO and FES devices was being done in other CNO disorders (Brehm, Harlaar, & 
Schwartz, 2008; Esnouf, Taylor, Mann, & Barrett, 2010; Mann, Finn, & Taylor, 2008; Paul et 
al., 2008; Sheffler et al., 2009) but at the time of the review there were no published 
comparative RCTs and so the generalizability of the systematic review could be questioned. 
The devices however are foot-drop impairment as opposed to diagnosis specific so the 
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impact of the results being from stroke participants alone on the generalizability of the 
conclusions drawn is unknown. 
Participants of three of the 5 studies (Kluding et al., 2013; Kottink et al., 2007, 2012; 
Salisbury, 2013) received concurrent physiotherapy. Therapy is indicated up to a year post-
stroke (Teasell et al., 2003) but Kluding et al (2013) and Kottink et al (2007; 2012) recruited 
participants on average 4.77 and 9.07 years’ post-stroke respectively. Therefore, these two 
studies do not represent standard clinical practice which threatens their external validity 
and by extension this review.  
Prior to commencing the review there was detailed consideration of whether to focus on 
RCT level evidence or open the study type. The candidate chose to focus on RCT level 
evidence alone for three reasons: 
1. Consideration of the hierarchy of evidence and previous searches of the literature 
revealing the potential to focus at this level (1a) only (Oxford centre for evidence-
based medicine, 2009).  
2. Critique of other reviews in the field. 
3. Any update in guidelines would give greatest weight to this level of evidence 
However it is recognised that the decision to do this excluded device specific evaluation 
studies (Medical Research Council, 2006) which, although individually at higher risk of bias 
and likely underpowered, might have provided a more detailed insight into effects.  
The included RCTs were primarily conducted in North America where the healthcare system 
differs significantly from the UK system. This could be construed to undermine the 
applicability of the review results to the UK. However, the purpose of this review was to 
compare efficacy and explore possible mechanisms-of-action of the foot-drop AT 
interventional devices based on RCT level evidence. Therefore, any variation in any other 
interventions participants received should not influence our findings as between group 
heterogeneity was not found. 
Only measures that evaluated the combined-orthotic effects on walking were considered by 
the review. Given that both devices have been shown to positively influence balance 
(Dunning et al., 2015; Tyson & Kent, 2013) the decision to disregard postural sway and/or 
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functional balance measures might have been remiss. This was justified due the desire to 
keep a clear focus on walking effects.  The combined-orthotic effect was chosen because of 
its clinical relevance given this is how most AFOs and indeed FES are prescribed (Bosch et 
al., 2014) and yet the guidelines lack advice on which of these to use for which patient to 
target combined-orthotic effects. 
It is recognised by the candidate that there was an error in data extraction by reporting that 
one trial recruited  new AFO users when in fact there was a combination of new and current 
users (Bethoux et al., 2015; Bethoux et al., 2014). Whilst this does not directly impact the 
results and conclusions of the review it is misleading to readers. This was an oversight by 
the candidate. 
Despite some limitations this review provided the first gold standard comparison of the two 
devices used in a clinically applicable way (combined-orthotic). Quality was assured through 
the use of recognised guidelines (Higgins et al., 2011; Liberati et al., 2009) and therefore 
there can be confidence in the findings that AFOs produce equal improvements in some 
activity and participation walking measures. It was also able to highlight the limitations in 
the current RCT evidence base; most notably the lack of device details and the inability to 
further the understanding of the mechanism-of-action for either device. This article 
therefore has the potential to impact future clinical guidelines by providing direction for 
future comparative RCTs. 
As previously discussed in Chapter 1, there is a view that FES use may encourage the return 
of voluntary control over foot and ankle musculature (Rushton, 2003); conversely some 
authors propose that the use of a passive AFO may lead to deterioration in volitional Tib Ant 
muscle activity (Hesse et al., 1999; Lairamore et al., 2011; Romkes et al., 2006). This review 
raised a further question for the candidate about whether these claims were substantiated. 
 
2.6 Article 6 
Prenton, S., Hollands, K., Kenney, L.P.J. Onmanee, P. (2018) Which to use for therapeutic 
improvement of foot-drop: functional electrical stimulation or ankle foot orthoses? A meta-
analysis that gives clear direction for future research. Journal of Rehabilitation Medicine, 50, 
129-139. doi: 10.2340/16501977-2289.   
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2.6.1 Article Summary  
As with Article 5 this article sought to fill the second gap in the evidence base identified by 
the candidate; that both devices lack foot-drop specific and user-important evaluation 
measures. It also sought to fill the third identified gap in the evidence base of a lack of 
clinical guidance about which device was better overall. 
Based on this further question regarding the potential, conflicting, mechanisms-of-action on 
volitional muscle activation this review 
(https://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015025967 ) 
compared the effects of the two devices whilst they were not being worn following a period 
use.  
This review identified primary measures of interest based on those that could evaluate the 
hypothesised claims around the therapeutic effects on volitional muscle activity and those 
that were foot-drop specific and known to be used in the field. These were 
electromyography (EMG) to evaluate the effect on volitional muscle activity and ankle 
kinematics at IC to evaluate the effect on the transition from swing to stance. As the 
candidate knew they were the first to use foot clearance as an evaluation measure 
(ShefStim® study, Article 3), although (Kim et al., 2004) had previously reported on toe 
clearance, this was not identified. 
Actual walking performance was the functional primary measure of interest to compare the 
effects in the users’ own environment. As the candidate was already aware that device 
usage data was not routinely collected any form of activity monitoring was identified to 
capture actual walking performance. All walking measures, including those of primary 
interest, were extracted and categorised as BFS or functional. 
Similar procedures to Article 5 were used to source, screen, data extract and then quality 
assess appropriate trials. This resulted in seven RCTs, from eight publications, with 464 
participants. Only walking speed over 10 metres was collected frequently enough by the 
included RCTs to be meta-analysed. Sub-group analysis of overall effects on the walking 
speed over 10 metres for stroke and following four-six weeks’ use was also possible. Meta-
analysis indicated equal, positive, improvement for both devices both overall and after only 
four-six weeks use. This was also true for the sub-group analysis based on the six stroke 
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RCTs. None of the three identified primary measures of interest were used consistently 
enough to meta-analyse but were used sufficiently to allow a narrative summary. This 
narrative summary found equal changes for both devices with regards kinematics and the 
EMG findings from a single trial (Kottink et al., 2008) found therapeutic differences between 
FES and AFO use. The way in which activity monitoring was used proved to be problematic; 
two trials collected this data, but one did so during the intervention period which was more 
likely (but not explicitly defined) to indicate activity whilst the device was being worn rather 
than a therapeutic effect (when the device was not being worn).  This meant that the ability 
to interpret the results was very limited. 
This review was the first to statistically show that AFO use has a positive therapeutic effect 
on walking speed. This is a novel contribution to the field. It also demonstrated that the size 
of the improvement is the same as the observed improvement following FES use for non-
progressive CNO disorders as well as for stroke alone and after four-six weeks use. Due to 
the measures used to comparatively evaluate the two devices the included RCTs were not 
able to show how these improvements were achieved or whether this translated into actual 
walking performance, as the primary measures of interest were not used sufficiently. As 
such it gave a very clear direction for future comparative RCTs, thereby extending the 
discipline and adding to the theoretical base. 
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2.6.2 Candidate involvement7 
The candidate’s involvement mirrored that for Article 5 (2.5.2). This work was a poster 
presentation at the International Society for Posture and Gait Research Conference (ISPGR) 
in Florida July 2017 (Appendix 3d). 
2.6.3 Critical appraisal 
This review is in many ways similar to Article 5 and therefore the same critique discussed in 
section 2.5.3 applies. As with Article 5 the publication dates of the included trials were 
clustered around a similar time period to the combined-orthotic studies (2008-2013) with 
five of the eight publications, from four of the seven trials, being published over 2 years 
(2012-2013). This is not surprising given that some of the same trials were included in both 
the combined-orthotic (Article 5) and therapeutic (Article 6) reviews (Everaert et al., 2013; 
Kluding et al., 2013; Salisbury et al., 2013). Therefore, the common issues around selection 
bias and choice of outcome measures might be due to studies not being able to learn from 
each other. Again device details were not reported and there was an overuse of standard 
functional measures, most prominently walking speed. No progressive CNO disorders were 
recruited with stroke primarily focused on although, unlike in Article 5, one RCT did focus on 
another diagnosis (CP) (van der Linden, Hazlewood, Hillman, & Robb, 2008). And here again 
3 of the 7 studies (Kluding et al., 2013; Kottink et al., 2008; Salisbury et al., 2013) provided 
concurrent physiotherapy alongside the foot-drop device which threatens the external 
validity of the former two. The same rationale why only RCTs and walking measures 
presented for Article 5 applies. Again it should be noted that there was an inaccuracy in one 
aspect of the extracted data. It was wrongly reported that in the trial by Sheffler et al 
(Sheffler et al., 2015; Sheffler et al., 2013) the foot-drop devices were only used under 
supervision. Whilst this appeared to be the focus of the intervention participants also used 
the devices at home. This oversight was most probably due to the decision to allow a single 
author, the candidate, to extract data with a second person checking for accuracy rather 
than having two independent people doing this. Again errors such as these do not impact on 
the review results and conclusions but the candidate did in no way wish to misrepresent the 
included trial authors, so regrets this error.  
                                                          
7 A summary of the candidate’s involvement in each article is presented in Table 1 on page 5 
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Where this article differed to the previous review on combined-orthotic effects of AFO 
versus FES was in relation to its specificity and findings. The development of this review 
benefitted from the knowledge of the relevant evidence base built up when writing the first 
review. Therefore, unlike Article 5, the candidate specifically chose and justified primary 
measures of interest. The chosen measures, activity monitoring, EMG and ankle kinematics 
at IC, were indeed found to be underused and overall there was a lack of justification as to 
the choice of measures used in the included trials. As such this review was able to very 
clearly direct future research to use similarly justified, credible and robust measures in 
future. 
Although the narrative summary covered a range of evaluation measures the meta-analysis 
was limited to walking speed over ten metres. This limited the conclusions that could be 
drawn, but emphasised the variation in the measures chosen by the included trials and the 
need to address this if the second identified gap in the evidence base is to be filled. With 
respect to the primary measures of interest, narratively there was a suggestion that EMG is 
effected in different ways by the two devices in favour of FES, a view which was supported 
by other non-RCT sources. However, no further comment could be made about whether this 
indicated that FES produces recovery and AFOs compensation. The two trials that evaluated 
the therapeutic effects on kinematics found different results with (van der Linden et al., 
2008) observing an equal, but insignificant, improvement in knee flex at IC and DF through 
swing. (Sheffler et al., 2015) found no significant effect from either device on peak hip flex in 
swing, peak knee flex in swing, DF at IC, peak ankle abduction in swing, peak ankle external 
rotation in swing. In contrast both groups showed a significant reduction in peak ankle DF in 
swing after 12 weeks use and 12 weeks’ post-use; but this was not found 24 weeks after 
finishing using the device. This further highlighted the importance of future researchers 
adopting common and clearly justified measures. Whilst not appropriate to mention in the 
manuscript, the candidate believes that toe (Kim et al., 2004) or foot clearance should 
feature in this battery of mechanism-of-action measures (Prenton, Kenney, Stapleton, et al., 
2014; Thies, Jones, et al., 2011) given its justification in the ShefStim® study of Part 1 (Article 
3). 
The final point that should guide the field was with regards the notion of therapeutic effect 
itself. Most RCTs captured this at the end of the intervention period, indeed this is when it 
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has been observed in other generic reviews (Pomeroy, King, Pollock, Baily-Hallam, & 
Langhorne, 2006). This review challenged the clinical applicability of this notion and 
introduced the concept of a sustained therapeutic effect that was detailed in Chapter 2 
(Figure 3). Therefore, overall, and building on what was reported in Article 5, this article 
gives specific direction for future comparative RCTs which has the potential to influence 
future clinical guidelines. 
 
2.7 Conclusions and Future Work 
The articles that contribute to this thesis, and the thesis itself, sit within the body of 
evidence that seeks to evaluate and compare foot-drop AFO and FES devices. It adds to 
previous work which recognises that in order to do this in a meaningful way direct 
mechanistic measures of the foot-drop impairment (Tyson et al, 2013; Kottink et al, 2012; 
Kim et al, 2004; Voigt & Sinkjaer, 2000) alongside measures which capture the effects on the 
walking behaviours of the user in their own environment (Kluding et al, 2013, van Swigchem 
et al, 2010, Stein et al, 2006) and usability (Arthranat et al., 2007; Choi & Springle, 2011) are 
what are now needed in order to further develop our understanding of how the devices 
work and which is better overall; with a view to enhancing current clinical guidance.  
The HTD480 project team members identified a researcher/user co-design process would be 
beneficial in the development of new interventional AT foot-drop devices. This approach 
was subsequently extended to user input to study design at the candidate’s suggestion 
(Williamson et al, 2014). The co-design approach used by the HTD480 project was shown to 
be feasible and led to positive changes in both product and study design. However, how this 
approach compares with any alternative cannot be commented on, as no comparisons with 
other co-design methods were made. PART 1 of this thesis charts the involvement of the 
candidate in a funded project focussed on doing this for both devices. The candidate 
recognises that the methodological decisions made in relation to the two empirical studies 
of the devices (Article 2 and 3) do not allow conclusions to be drawn regarding the efficacy 
of either device. However, the studies (Kenney et al, 2016; Prenton, Kenney, Cooper, et al, 
2014; Prenton, Kenney, Stapleton, et al, 2014) demonstrated the feasibility of the devices 
for the first time using some methods and measures previously not used in the field that 
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might help to more fully understand the usability of these devices. There were many points 
to come from PART 1 of my work, as discussed earlier in this Chapter of the thesis. Three 
key points that would be useful for future researchers in this field were: 
1. The positive impact of user/researcher co-design processes to inform study design as 
well as the development of new devices. 
2. The use of foot, as opposed to toe, clearance as a direct mechanism-of-action 
measure for arguably the fundamental issue caused by foot-drop; clearance through 
the swing phase of gait. 
3. The importance of evaluating device usage and usability as ultimately foot-drop 
devices are only of any real value if they can and are used in the person’s own 
environment. 
The candidate then focussed on asking whether one type of device was more effective 
overall than the other (PART 2) so as to establish the evidence for clinical recommendations 
on which device to use for which purpose in the face of increasing numbers of 
manufacturers and versions of both devices. This was felt to be best served by making 
clinically relevant comparisons. Therefore, trials that compared both devices as long-term 
orthotics was the most logical focus of the first meta-analysis (Article 5). Due to the weight 
given to RCTs within guidelines, the availability of RCTs at this point in the candidate’s work 
and the lack of any previous statistically robust reviews this was timely. There were 
opposing views on the long-term effects of each device on the lower limb when the devices 
were removed (therapeutic effects). Thus therapeutic comparisons were also clinically 
relevant (Article 6). The candidate acknowledges that both reviews in PART 2 have 
limitations related to the reviewed trials, the decision to focus on a single level of evidence 
and minor errors in data extraction. However, and building on previous reviews in the field, 
both reviews showed device comparability with the meta-analyses importantly revealing 
statistically significant device comparability for speed, exercise capacity and the mobility 
sub-scale of the SIS with regards combined-orthotic effects (Prenton et al, 2016) and 
therapeutic speed increases (Prenton et al, 2018). These were surprising results which, as 
discussed in the articles themselves, the candidate suggests may be due to one of more of 
the following three reasons: 
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1. Both interventional AT foot-drop devices increase task-specific repetitive activity and 
it is this alone that produces the observed effects on walking behaviours. If this is the 
case then it does not matter which you use. Such an outcome could lead to AFOs 
being prescribed more frequently than FES, given their lower costs at the point of 
prescription, despite FES showing long term cost effectiveness (National Health 
Service Purchasing and Supply Agency, 2010; Taylor, Humphreys, & Swain, 2013) and 
bearing in mind that either device is only cost effective if it used. 
2. Speed increases might be due to compensation as opposed to restoration of 
volitional muscle activity for either or both devices (Langhorne et al., 2009). Speed 
increase is of limited direct value unless there is translation into the real life of the 
user. 
3. It might be due to the chronic, non-degenerative and hence relatively stable 
populations studied by the included trials. The data collection periods used in the 
included studies might therefore not be long enough to highlight any differences. 
Due to their focus these reviews have shown the gaps in the comparative RCT evidence base 
in terms of the choice of measures used. Current clinical guidelines cannot comment on how 
each device works which might help to indicate which people they may be best used for 
(Tyson et al., 2013). While the primary aim of the included studies was not to determine the 
mechanisms-of-action of the devices the candidate examined the included studies for any 
evidence that might aid clinicians to choose the best device for their clients. It was 
concluded that further information regarding the biomechanical effects of both devices was 
needed to make this possible. Guidelines are also unable to comment on if and how devices 
are used outside of a laboratory or their usability. The reviews in PART 2 (Articles 5 & 6) 
highlight that this lack of focus on foot-drop specific and user-important functional 
measures persists in more recent RCTs and suggest what measures might increase our 
understanding of the mechanisms-of-action and how the devices impact the user in their 
own environment. So although these reviews do not advance our understanding of how the 
devices work or if and how they impact the user in their “real-life” per se, the findings could 
inform the design of better future RCTs in this field. 
The reviews also highlighted that the current RCTs recruited non-progressive populations 
(overwhelmingly stroke) which limit their generalizability to all CNO disorders where foot-
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drop occurs as well as a lack of reported device details which would allow clinicians and/or 
further studies to replicate devices.   
The application of novel ways of developing and evaluating new devices, with 
user/researcher co-design, in PART 1 and the highlighting of the limitations with recent RCTs 
in PART 2 has demonstrated the importance of measurement of both parameters which 
may reflect mechanisms-of-action and appropriate functional measures. PART 1 in 
particular has also demonstrated how public involvement and a focus on usability may help 
with future device compliance. In contrast to the findings in PART 2 of this thesis, which 
focused on the results from the limited RCT evidence base, it is clear that many users of 
either intervention do not consider them to be equivalent in their effect (Everaert et al., 
2013; Kluding et al., 2013). Everaert et al (2013) found 70% (p<0.001) of their participants 
who were new users of either device chose FES (Walkaide®) over AFO after 12 weeks use 
citing function, confidence, comfort, convenience, easy donning/doffing and safety as 
reasons for preferring either device. Kluding et al (2013) used a self-developed user 
satisfaction survey finding significantly higher satisfaction in the FES (Bioness ®) group after 
12 and again after 30 weeks use. This differences were significant for eight of the 12 
questions relating to: enthusiasm about continuing to use; comparison to other walking 
devices, convenience in using all day long, confidence in performing tasks whilst wearing, 
confidence in walking on inclines and/or uneven ground, comfort in social situations, 
whether they would use the device daily and whether they would recommend the device. 
The results might have been influenced by the decision to recruit current AFO users and the 
use of a purposive survey using three point Likert scales or yes/ no responses. Nevertheless, 
it is imperative that further study is undertaken that explores this mismatch. Based on the 
work contained in this thesis, the candidate proposes that a Phase III trial (Medical Research 
Council, 2000) is required which uses foot-drop specific and user-relevant outcome 
measures to compare the two types, AFO and FES, of AT interventional foot-drop devices. 
Based on my work I recommend that the foot-drop specific measures should be foot-
clearance and, given the potential impact of foot-drop devices on the entire lower limb and 
throughout the gait cycle, EMG, kinematic and kinetic measures. Further, device usage as 
well as the physical activity of the user when not wearing the device should be recorded to 
both capture a potential mechanism-of-action (task-specific repetitive activity) as well as the 
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impact of the devices on participation. Participant views whilst invaluable to understand 
user experience and to inform methodological decisions are susceptible to social desirability 
bias (Grimm, 2010) when captured in the context of an efficacy trial using purposive 
questionnaires (Everaert et al., 2013; Kluding et al., 2013; Prenton, Kenney, Cooper, et al., 
2014). Due to validation processes data collection tools such as the QUEST 2.0 allow a more 
robust approach to the collection of user satisfaction data (Koumpouros, 2016). Although 
generic to any AT the questions asked by the QUEST 2.0 device sub-scale (Appendix 4) 
reflect what Kluding et al (2013) was also trying to explore by asking about comfort and 
convenience, but with the benefit of construct validity. An alternative would be to adopt a 
mixed methods approach. This combination of measures would shift the emphasis of 
evaluation from the laboratory to the real life of the user where effects are most important; 
which was apparent as being important to potential end-users during the lay-advisory group 
meetings that accompanied the HTD480 project (Williamson et al., 2013). Further lay-
advisory work is needed to confirm whether this proposed raft of measures fully reflects 
user priorities. With regards recruitment the candidate suggests that all participants should 
be new users of either device so as to not bias preference. Recruitment should also focus on 
people who present with a range of CNO disorders; albeit progressive and non-progressive 
participants will require sub-group analysis. In addition to this, based on the work contained 
in this thesis, the candidate recommends that details of prescription processes (mechanical 
properties (AFO), setup parameters (FES)) must be reported and devices should be set up by 
users during data collection sessions to reflect real use. Due to the variation in types of AFO 
and FES used in clinical practice and the impact this heterogeneity has on the potential 
mechanisms-of-action, either one type of AFO and one type of FES system should be used, 
or the recruitment be sufficient to allow sub-group analysis. Both combined-orthotic and 
therapeutic effects should be evaluated. The study period should be at least 42 weeks in 
duration (Dunning et al., 2015) with data collected every 6 weeks. The reasons for this are 
linked to the findings of effects after 6 weeks and 12-13 weeks (Prenton et al., 2016) and the 
necessity of longer study periods to potentially differentiate between the devices if 
participants have chronic conditions (Prenton et al, 2016). However, it is recognised that 6 
weekly data collection points is not indicative of clinical practice which could undermine 
external validity. The impact of more frequent data collection points would have to be 
weighed against the increased risk to recruitment and attrition; getting this balance right 
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might be best achieved by seeking lay advice. Post-device use follow-up is also necessary if 
sustained therapeutic effects are to be compared (Prenton et al, 2018).  
If these recommendations are utilised the future trials undertaken will then create the 
opportunity for the development of more specific clinical guidance based on a clearer 
understanding of the devices’ mechanisms-of-action, if/how they are used outside of a 
laboratory and whether/how that relates to the usability of the devices. 
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CHAPTER 3: IMPACT 
The potential impact of the work presented in this thesis is best summarised according to 
identified gaps, how they have been addressed and the suggestions made regarding where 
future work in the field should focus. As stated in the conclusion & future work section in 
Chapter 2 (2.7) the substantial body of work within this thesis as based on the identified 
gaps in the evidence base, were underpinned by the candidate’s focus of how devices for 
foot-drop are most credibly evaluated if future foot-drop clinical guidance is to be advanced. 
This was achieved through the creation of new knowledge in the form of the three studies 
that formed PART 1 as well as the synthesis and interpretation of existing evidence 
presented in PART 2. The candidate conceptualised key elements within all of these studies 
and used applicable and rigorous techniques in the enquiry undertaken (Articles 2, 3, 5, 6). 
In so doing the candidate fulfils the four Quality Assurance Agency (QAA) Framework for 
Higher Education Qualifications (FHEQ) descriptors for higher education qualifications at 
level 8 (Quality Assurance Agency, 2008) and has the potential to redirect the device for 
foot-drop evidence base. 
In addition to the overt conclusions related to the identified gaps in the evidence base to 
come from the presented body of works there are other areas of potential impact that three 
of the articles that constitute PART 1 provide. The lay-advisory group study (Article 1), the 
DMO dorsiflex sock® study (Article 2) and the ShefStim® study (Article 3) could be used by 
future researchers as examples of user involvement in device development, study design 
development and participant feedback within this field of research. Use of these articles 
could therefore facilitate translation of evidence for device efficacy into implementation as 
they illustrate how to implement user involvement which is necessary if AT is to align with 
the needs and expectations of the user (Wilkinson & De Angeli, 2014).  
It was recognised that the two devices that were studied (DMO dorsiflex sock® and 
ShefStim®) in PART 1 were complex interventions and subsequently appropriate 
methodological approaches to preliminarily evaluate them in line with appropriate guidance 
(Medical Research Council, 2000) at Phase I (lay advisory group) and Phase II (empirical 
studies of the two devices) were utilised. The demonstration of where devices might not 
work as hoped, DMO dorsiflex sock® study (Article 2), and where product refinement is 
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required for commercial partnership, ShefStim® study (Article 3), is impactful so that future 
development and research into those devices can be specifically targeted. 
Appendix 5 details the journals the body of work have been published in and some metrics 
pertaining to them. Citation metrics gauge the impact of individual scholarly impact. The 
Hirsch (h) index is the most useful summary measure of this (Birks et al., 2014) calculated 
based on the number of publications and the number of citations.  The h-index for the 
candidate currently stands at 3. Whilst a low number (Birks et al., 2014) considering the 
timespan of the articles publications (2014-2018) and the proximity of thesis submission to 
that period of time there is evidence that the candidate is having some scholarly impact in a 
relatively short period (Saleem, 2011). The number of citations as a standalone metric is also 
relevant for consideration for a PhD by published works as an indication of author visibility 
(Nightingale & Marshall, 2013). It should be noted that Article 6 was in the process of 
publication around the time of submission. As such its impact cannot be judged at this time. 
Article Google scholar SCOPUS ResearchGate 
1 8 4 4 
3 9 6 8 
4 2 1 1 
5 4 2 2 
Table 3: Article Citations8 
 
 
 
 
 
                                                          
8 Accurate as of 11/1/18 
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research, case studies, systematic reviews and product development and testing. 
Theoretical and conceptual papers and the discussion of professional issues and 
international/national policies and standards are also published. 
ISSN: 1748-3107 
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Journal is operated from London, England 
Aims & Scope 
Prosthetics and Orthotics International is an international, multidisciplinary journal for all 
professionals who have an interest in the medical, clinical, rehabilitation, technical, 
educational and research aspects of prosthetics, orthotics and rehabilitation engineering, as 
well as their related topics. 
The Journal publishes review articles, experimental and clinical research papers, case 
studies, technical notes, reports on prosthetics, orthotics and rehabilitation engineering 
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The Archives of Physical Medicine and Rehabilitation is the official journal of the ACRM | 
American Congress of Rehabilitation Medicine, an organization focused on the creation and 
use of knowledge in the rehabilitation process. The Archives of Physical Medicine and 
Rehabilitation publishes original, peer-reviewed research and clinical reports on important 
trends and developments in medical rehabilitation and related fields. 
This international journal brings researchers and clinician’s authoritative information on the 
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comprehensive care for individuals with chronic illness and disabilities. The journal's content 
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Mission Statement  
The mission of the Archives of Physical Medicine and Rehabilitation is to disseminate original 
information, with the goal of advancing the art and science of interdisciplinary 
rehabilitation, thus improving the health and welfare of persons with chronic illness and 
disabilities and reducing the cost of care. 
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notes. Our focus encompasses the application of the basic principles of physics and 
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of producing improvements in the quality of health care. Topics covered include 
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Original articles, reviews, case reports, short communications, special reports and letters to 
the editor are published, as also are editorials and book reviews. The journal strives to 
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intervention studies, clinical studies in various patient groups, methodology in physical and 
rehabilitation medicine, epidemiological studies on disabling conditions and reports on 
vocational and sociomedical aspects of rehabilitation. 
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rehabilitation medicine, neurology, clinical neurophysiology, general medicine, 
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welcome 
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